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Introduction {#jcsm12502-sec-0001}
============

Dependence in activities of daily living (ADLs), the basic tasks required of an individual to maintain their independence at home, is associated with increased risk of morbidity and mortality.[1](#jcsm12502-bib-0001){ref-type="ref"}, [2](#jcsm12502-bib-0002){ref-type="ref"} Individuals that are dependent in ADL are also likely to be dependent in instrumental activities of daily living (IADLs), the tasks required of an individual to maintain their independence in the community.[3](#jcsm12502-bib-0003){ref-type="ref"}, [4](#jcsm12502-bib-0004){ref-type="ref"}, [5](#jcsm12502-bib-0005){ref-type="ref"} The prevalence of ADL and IADL disability for at least one activity is 34.6% and 53.5%, respectively, in adults aged 65 years and older,[6](#jcsm12502-bib-0006){ref-type="ref"} and this prevalence increases with age.[7](#jcsm12502-bib-0007){ref-type="ref"} Those with lower muscle measures, defined by muscle mass, muscle strength, and physical performance,[8](#jcsm12502-bib-0008){ref-type="ref"} are more likely to be dependent in ADL and/or IADL.[9](#jcsm12502-bib-0009){ref-type="ref"}, [10](#jcsm12502-bib-0010){ref-type="ref"}, [11](#jcsm12502-bib-0011){ref-type="ref"} The more difficult tasks are for an individual, the more effort and demand they require relative to their muscle\'s maximum capacity.[12](#jcsm12502-bib-0012){ref-type="ref"}

Older adults that develop ADL dependence are less likely to recover function, stressing the need for strategies that can prevent or delay the onset of ADL dependence.[13](#jcsm12502-bib-0013){ref-type="ref"} Higher muscle strength is protective against declining below the threshold where dependence in ADL and IADL occurs.[14](#jcsm12502-bib-0014){ref-type="ref"} In community‐dwelling older adults, physical performance measured by gait speed has been shown to be a strong predictor of ADL disability.[15](#jcsm12502-bib-0015){ref-type="ref"}, [16](#jcsm12502-bib-0016){ref-type="ref"} Similarly, low muscle mass, muscle strength, and gait speed have all been associated with an impaired ability to perform ADL and IADL.[17](#jcsm12502-bib-0017){ref-type="ref"}, [18](#jcsm12502-bib-0018){ref-type="ref"} Currently, there are no systematic review and/or meta‐analyses that quantifies the association between muscle mass, muscle strength, and physical performance as predictors of ADL and IADL dependence. By determining which muscle measures are predictive of ADL and IADL dependence allows for the identification of individuals at high risk of decline as well as the development and implementation of strategies that can prevent or delay the onset of dependence.

The aim of this systematic review and meta‐analysis was to determine if muscle mass, muscle strength, or physical performance are predictors of ADL and/or IADL at follow‐up in older populations.

Methods {#jcsm12502-sec-0002}
=======

Search strategy {#jcsm12502-sec-0003}
---------------

This systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta‐analyses and registered with the PROSPERO International Prospective Register of Systematic Reviews (CRD42019125666).[19](#jcsm12502-bib-0019){ref-type="ref"} The following four electronic databases were screened for potential relevance from date of inception to 7 June 2018: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Cumulative Index of Nursing and Allied Health Literature. The search strategy was developed in consultation with a senior tertiary librarian from The University of Melbourne, with expertise in research and search strategies. The following terms were used in the search strategy: 'muscle mass', 'fat free mass', 'lean mass', 'muscle loss'/atrophy, 'muscle strength', 'physical performance'/mobility/fitness/endurance, 'activities of daily living', 'functional decline'/disability, and aged/elderly/older. The full search strategy can be found in Supporting Information, *Table* [*S1*](#jcsm12502-supitem-0001){ref-type="supplementary-material"}.

Eligibility criteria {#jcsm12502-sec-0004}
--------------------

Inclusion criteria consisted of prospective longitudinal cohorts of older adults with a reported mean/median age of 65 years and older at follow‐up and reporting at least one of the following measurements: muscle mass, muscle strength, or physical performance in conjunction with a follow‐up outcome of ADL or IADL.

Exclusion criteria included cross‐sectional and case--control studies; anthropometric measurements as measures of muscle mass such as body mass index, hip‐waist ratio, waist or calf circumference measurements, and skin‐fold thickness; populations that suffered from cancer, muscular dystrophy, genetically inherited diseases, and HIV/AIDS; cohorts that received an intervention other than usual care or placebo; and non‐English articles. Articles including participants of the same cohort more than once were excluded in a hierarchical manner: (i) if there was no statistical analysis conducted regarding odds ratio (OR), hazards ratio, or relative risk and lacking data to calculate the OR; (ii) if their primary research question was not exploring the association between muscle measures with ADL or IADL; or (iii) an article had a smaller sample size.

Article selection {#jcsm12502-sec-0005}
-----------------

Articles obtained through the search strategy had their title and abstract screened followed by full‐text screening for eligibility independently by two authors (D. W., Y. Z., or J. Y.) using Covidence (Covidence Systematic Review Software, Veritas Health Innovation, Melbourne, Australia). The decision made by authors was compared, and conflicts were settled by a third reviewer (E. M. R.).

Data extraction and quality assessment {#jcsm12502-sec-0006}
--------------------------------------

Data extraction was performed by two authors (D. W., Y. Z., or J. Y.). The following data were extracted from included articles: author, year, study/cohort, setting, country/region, demographical information \[sample size, age (mean/median), and sex (% female)\], and follow‐up duration. Muscle mass, muscle strength, physical performance, ADL, and IADL were extracted based on the measurement method, unit, and cut‐offs applied in analyses. Effect sizes were extracted from text, tables, or figures if not described elsewhere.

The quality of the included articles was assessed by a modified version of the Newcastle--Ottawa Scale (NOS) for cohort studies.[20](#jcsm12502-bib-0020){ref-type="ref"} Quality assessment was performed based on the following categories: selection, comparability, and outcome. Articles were deemed to be high quality with the following criteria: (i) the population was representative of the 65 years and older at follow‐up; (ii) in the case of a dichotomized sarcopenic cohort (low muscle mass, muscle strength, and physical performance), both cohorts were recruited from the same population; (iii) the technique used to measure muscle mass, muscle strength, or physical performance; (iv) the analysis was controlled for age and/or sex, as well as other factors; (v) ADL or IADL was measured with a validated method or a study designed questionnaire or survey; (vi) follow‐up duration was ≥3 months; and (vii) subjects were all followed up, accounted for or the number lost to follow‐up was unlikely to introduce bias (≤20%). The adapted version of the NOS can be found in Supporting Information, [*Supplementary Material 2*](#jcsm12502-supitem-0002){ref-type="supplementary-material"}. Studies above the median score (7/7 and 8/8) were the cut‐off point for articles of high quality.[21](#jcsm12502-bib-0021){ref-type="ref"}

Data synthesis and analysis {#jcsm12502-sec-0007}
---------------------------

Effect sizes were extracted and reported where associations were made between baseline muscle measures and follow‐up ADL and/or IADL. Inclusion into the meta‐analysis required articles to report an OR, hazards ratio, relative risk, or if the article provided sufficient information to calculate an OR for the association between baseline muscle measures and follow‐up ADL and/or IADL. Forest plots were generated for the graphical representation of the meta‐analysis. A random effect model was adopted to account for differences between articles.[22](#jcsm12502-bib-0022){ref-type="ref"} Articles were presented in order from the shortest to longest follow‐up duration to determine if follow‐up duration impacts effect size, i.e. longer follow‐up duration showing greater effect size. Articles that reported sex‐stratified results or ADL and IADL were entered in the meta‐analysis separately. The least adjusted statistical model consisting of age and sex was used in the meta‐analysis, followed by the next least adjusted model then the unadjusted model. Heterogeneity was measured using the *I*‐squared (*I* ^2^) test. Low heterogeneity was defined as an *I* ^2^ ≤ 25%, moderate as 25--75%, and high as ≥75%.[23](#jcsm12502-bib-0023){ref-type="ref"} The *P*‐value for significance was set at \<0.05, and the *P*‐value for a trend was set at 0.05 \< *P* \< 0.01. Meta‐analyses were performed separately according to the unit of gait speed, ADL, and IADL. The meta‐analysis was performed using Comprehensive Meta‐analysis (version 3.3; Biostat Inc., Englewood, NK).

Results {#jcsm12502-sec-0008}
=======

*Figure* [1](#jcsm12502-fig-0001){ref-type="fig"} presents the Preferred Reporting Items for Systematic Reviews and Meta‐analyses flow diagram of selected articles. The four databases yielded 12 950 potential articles to which an additional 13 were added by snowballing. After removing duplicate articles, 7760 progressed to title and abstract screening. Of these, 7535 articles were excluded resulting in 225 articles for full‐text screening. Ultimately, 83 articles were included in the systematic review and 45 articles in the meta‐analysis.

![Preferred Reporting Items for Systematic Reviews and Meta‐analyses flow chart for the study selection process.](JCSM-11-3-g001){#jcsm12502-fig-0001}

Characteristics of included articles {#jcsm12502-sec-0009}
------------------------------------

*Table* [1](#jcsm12502-tbl-0001){ref-type="table"} presents the study characteristics of included articles. The majority of the articles were conducted on community‐dwelling participants (*n* = 65/83). The mean or median age of the study ranged from 54 to 86 years at baseline. The number of participants in each study ranged from 41 to 8000 and included a total of 108 428 (54.8% female) participants. Follow‐up duration ranged from 11 days to 25 years. ADL was measured in 73 articles that examined physical motor tasks, 30 of which had developed an adapted questionnaire to assess the motor component of ADL (Supporting Information, *Table* [*S3*](#jcsm12502-supitem-0003){ref-type="supplementary-material"}) and 21 articles using the Katz Index or a modified version. Of the articles reporting ADL, 63 articles used a dichotomous cut‐off reporting a worsening ADL score (≥1 points loss, i.e. more dependency) at follow‐up compared with using a continuous ADL score (*n* = 11). IADL was measured in 35 articles with the Lawton--Brody IADL scale being used in 14 articles, three of which were modified. A total of 26 articles included measures of both ADL and IADL.

###### 

Characteristics of included studies and measured activities of daily living and instrumental activities of daily living

  Study characteristics                                                Participants       FU         ADL             IADL                                                                                                                     
  -------------------------------------------------------------------- ------------------ ---------- --------------- ------ ----------------------------------------------------- ------- ------ ------------------ ----------- ------------- ---------
  Abete (2017) [24](#jcsm12502-bib-0024){ref-type="ref"}               ---                CD         ITA             907    81.3 ± 6.5                                            56.7    2 y    Katz               ≥1 loss     ---           ---
  Al snih (2004) [25](#jcsm12502-bib-0025){ref-type="ref"}             HEPESE             CD         USA             2493   72.4 ± 6.2[a](#jcsm12502-note-0003){ref-type="fn"}    57.9    7 y    M Katz             ≥1 loss     ---           ---
  Albert (2015) [26](#jcsm12502-bib-0026){ref-type="ref"}              SITE               CD         USA             375    78.9 ± 5.8                                            68.9    2 y    ---                ---         AMPS          Cont
  Alexandre (2012) [27](#jcsm12502-bib-0027){ref-type="ref"}           SABE               CD         BRA             1634   68.6 ± 0.4                                            57.1    6 y    M Katz             ≥1 loss     ---           ---
  Amigues (2013) [28](#jcsm12502-bib-0028){ref-type="ref"}             EPIDOS             CD         FRA             975    79.9 ± 3.5                                            100.0   4 y    ---                ---         LB            ≥1 loss
  Arnau (2016) [29](#jcsm12502-bib-0029){ref-type="ref"}               ---                OP         ESP             252    81.7 ± 4.6                                            58.7    1 y    BI                 ≥10 loss    M LB          ≥1 loss
  Artaud (2015) [30](#jcsm12502-bib-0030){ref-type="ref"}              3C                 CD         FRA             3814   73.2 ± 4.6                                            60.9    11 y   M Katz             ≥1 loss     LB            ≥1 loss
  Basic (2017) [31](#jcsm12502-bib-0031){ref-type="ref"}               ---                IP         AUS             1693   81.9 ± 7.5                                            61.5    11 d   M BI               ≥1 loss     ---           ---
  Baumgartner (2004) [32](#jcsm12502-bib-0032){ref-type="ref"}         NMAPS              CD         USA             451    72.7 ± 6.3[a](#jcsm12502-note-0003){ref-type="fn"}    61.9    8 y    ---                ---         Own Q         ≥1 loss
  Beauchamp (2015) [33](#jcsm12502-bib-0033){ref-type="ref"}           Boston RISE        PB         USA             360    76.6 ± 7.0                                            68.0    2 y    LLFDI‐FC           Cont        ---           ---
  Beloosesky (2009) [34](#jcsm12502-bib-0034){ref-type="ref"}          ---                OP         ISR             93     81.2 ± 7.2                                            69.5    6 m    Own Q              Cont        ---           ---
  Bianchi (2015) [35](#jcsm12502-bib-0035){ref-type="ref"}             InCHIANTI          CD         ITA             538    77.1 ± 5.5                                            53.5    9 y    ---                ---         LB            ≥1 loss
  Broadwin (2001) [36](#jcsm12502-bib-0036){ref-type="ref"}            ---                CD         USA             1051   70.7[a](#jcsm12502-note-0003){ref-type="fn"}          60.3    4 y    Own Q              ≥1 loss     ---           ---
  Carriere (2005) [37](#jcsm12502-bib-0037){ref-type="ref"}            EPIDOS             CD         FRA             545    79 (76--81)                                           100     7 y    ---                ---         LB            ≥1 loss
  Cesari (2015) [38](#jcsm12502-bib-0038){ref-type="ref"}              InCHIANTI          CD         ITA             991    73.9 ± 6.7                                            57.0    9 y    Katz               ≥1 loss     LB            Cont
  Chan (2014) [39](#jcsm12502-bib-0039){ref-type="ref"}                ISCOPE             CD         USA             764    83 (79--87)                                           68.2    1 y    GARS               Cont        GARS          Cont
  Chaudhry (2010) [40](#jcsm12502-bib-0040){ref-type="ref"}            CHS                CD         USA             5888   72.4[a](#jcsm12502-note-0003){ref-type="fn"}          57.6    7 y    Own Q              ≥1 loss     ---           ---
  Chu (2006) [41](#jcsm12502-bib-0041){ref-type="ref"}                 ---                CD         HKG             1419   73.1 ± 6.2                                            49.5    1 y    M BI               ≥1 loss     LB            ≥1 loss
  Cooper (2011) [42](#jcsm12502-bib-0042){ref-type="ref"}              LASA               CD         NLD             1532   70.0 ± 8.5                                            54.8    3 y    Own Q              ≥1 loss     ---           ---
  Corsonello (2012) [43](#jcsm12502-bib-0043){ref-type="ref"}          PVC                IP         ITA             506    80.1 ± 5.9                                            54.3    1 y    M Katz             ≥1 loss     ---           ---
  Costanzo (2018) [44](#jcsm12502-bib-0044){ref-type="ref"}            InCHIANTI          CD         ITA             709    73.4 ± 6.5                                            56.3    6 y    Katz               ≥1 loss     ---           ---
  Den Ouden (2013) [45](#jcsm12502-bib-0045){ref-type="ref"}           PROFIEL            CD         NLD             625    62.3 ± 8.9                                            49.0    10 y   M Katz             ≥1 loss     ---           ---
  Denkinger (2010) [46](#jcsm12502-bib-0046){ref-type="ref"}           IRIE               CD         DEU             161    82 (58--93)                                           72.7    3 w    BI                 Cont        ---           ---
  Di Monaco (2015) [47](#jcsm12502-bib-0047){ref-type="ref"}           ---                CD         ITA             193    80.0 ± 7.7                                            100     6 m    BI                 ≥15 loss    ---           ---
  Donoghue (2014) [48](#jcsm12502-bib-0048){ref-type="ref"}            TILDA              CD         IRL             1819   72.8 ± 6.1                                            52.6    2 y    Own Q              ≥1 loss     Own Q         ≥1 loss
  Duchowny (2018) [49](#jcsm12502-bib-0049){ref-type="ref"}            HRS                CD         USA             8467   74.6 ± 7.0[a](#jcsm12502-note-0003){ref-type="fn"}    57.0    2 y    Own Q              ≥1 loss     ---           ---
  Fantin (2007) [50](#jcsm12502-bib-0050){ref-type="ref"}              ---                CD         ITA             159    71.4 ± 2.3[a](#jcsm12502-note-0003){ref-type="fn"}    61.0    6 y    Own Q              ≥1 loss     Own Q         ≥1 loss
  Femia (1997) [51](#jcsm12502-bib-0051){ref-type="ref"}               OCTO Project       CD         SWE             95     86.8 ± 2.3                                            74.0    4 y    Own Q              Cont        Own Q         Cont
  Fujiwara (2016) [52](#jcsm12502-bib-0052){ref-type="ref"}            TMIG‐LISA          CD         JPN             981    71.5 ± 5.2                                            58.1    8 y    Own Q              ≥1 loss     ---           ---
  Giampaoli (1999) [53](#jcsm12502-bib-0053){ref-type="ref"}           FINE               CD         ITA             140    76.5 ± 3.4[a](#jcsm12502-note-0003){ref-type="fn"}    0       4 y    WHO scale          ≥1 loss     WHO scale     ≥1 loss
  Gill (1996) [54](#jcsm12502-bib-0054){ref-type="ref"}                PS                 CD         USA             775    79.1 ± 5.0                                            74      3 y    M Katz             ≥1 loss     ---           ---
  Gill (2009) [55](#jcsm12502-bib-0055){ref-type="ref"}                PEP                CD         USA             722    78.4 ± 5.2                                            62.4    11 y   Own Q              ≥1 loss     ---           ---
  Guralnik (2000) [56](#jcsm12502-bib-0056){ref-type="ref"}            EPESE              CD         USA             2478   ---                                                   ---     6 y    Own Q              ≥1 loss     ---           ---
  Hansen (1999) [57](#jcsm12502-bib-0057){ref-type="ref"}              ---                PB         USA             73     80.4 ± 7.0                                            66.0    1 m    Katz               ≥1 loss     M LB          ≥1 loss
  Heiland (2016) [58](#jcsm12502-bib-0058){ref-type="ref"}             SNAC‐K             CD         SWE             3060   73.7 ± 10.8                                           63.7    6 y    Own Q              ≥1 loss     ---           ---
  Hirani (2015) [59](#jcsm12502-bib-0059){ref-type="ref"}              CHAMP              CD         AUS             1819   77.3 ± 5.8[a](#jcsm12502-note-0003){ref-type="fn"}    0       5 y    M Katz             ≥1 loss     ---           ---
  Hirani (2017) [60](#jcsm12502-bib-0060){ref-type="ref"}              CHAMP              CD         AUS             1685   76.9 ± 5.5                                            0       5 y    M Katz             ≥1 loss     LB            ≥1 loss
  Hoeymans (1996) [61](#jcsm12502-bib-0061){ref-type="ref"}            Zitphen Elderly    CD         NLD             303    75.8 ± 5.4                                            0       3 y    M WHO              ≥1 loss     M WHO         ≥1 loss
  Hong (2016) [62](#jcsm12502-bib-0062){ref-type="ref"}                ---                CD         KOR             8000   72.5 ± 5.5                                            59.4    3 y    ---                ---         KIADL         ≥1 loss
  Idland (2013) [63](#jcsm12502-bib-0063){ref-type="ref"}              ---                CD         NOR             113    79.4 ± 2.9                                            100     9 y    M A PADL‐H scale   ≥1 loss     ---           ---
  Ishizaki (2000) [64](#jcsm12502-bib-0064){ref-type="ref"}            LISA               CD         JPN             583    70.9 ± 4.9                                            55.9    3 y    Own Q              ≥1 loss     TMIG IC       ≥1 loss
  Janssen (2006) [65](#jcsm12502-bib-0065){ref-type="ref"}             CHS                CD         USA             3694   73.5[a](#jcsm12502-note-0003){ref-type="fn"}          53.2    8 y    Own Q              ≥1 loss     ---           ---
  Jonkman (2018) [16](#jcsm12502-bib-0016){ref-type="ref"}             InCHIANTI, LASA    CD         ITA, NLD        798    67.5 ± 2.1[a](#jcsm12502-note-0003){ref-type="fn"}    53.8    9 y    Own Q              ≥1 loss     Own Q         ≥1 loss
  Kempen (1998) [66](#jcsm12502-bib-0066){ref-type="ref"}              GLAS               CD         NLD             557    72.4 ± 7.7[a](#jcsm12502-note-0003){ref-type="fn"}    74.7    2 y    GARS               Cont        ---           ---
  Kozicka (2016) [67](#jcsm12502-bib-0067){ref-type="ref"}             ---                CD         POL             41     69.8 ± 9.0                                            41.5    1 y    Katz               Cont        LB            Cont
  Kwon (2012) [68](#jcsm12502-bib-0068){ref-type="ref"}                ---                IP         USA             204    71.1 ± 5.3                                            57.8    1 y    HAQ                ≥1 loss     ---           ---
  Legrand (2014) [69](#jcsm12502-bib-0069){ref-type="ref"}             BFc80+             CD         BEL             431    84.4 ± 3.5                                            63.0    34 m   Own Q              ≥3 loss     ---           ---
  Lopez‐Teros (2014) [70](#jcsm12502-bib-0070){ref-type="ref"}         Coyoacan           CD         MEX             133    75.5 ± 4.7                                            53.4    1 y    Own Q              ≥1 loss     Own Q         ≥1 loss
  McGrath (2018) [71](#jcsm12502-bib-0071){ref-type="ref"}             HEPESE             CD         USA             672    81.7 ± 4.1                                            64.6    2 y    M Katz             ≥1 loss     OARS and RB   ≥1 loss
  Minneci (2015) [72](#jcsm12502-bib-0072){ref-type="ref"}             ICARe Dicomano     PB, HF     ITA             561    72.9 ± 7.1[a](#jcsm12502-note-0003){ref-type="fn"}    57.6    3 y    Own Q              ≥1 loss     ---           ---
  Moen (2018) [73](#jcsm12502-bib-0073){ref-type="ref"}                ---                PD         NOR             115    86.0 ± 5.9                                            55.0    3 w    Nor BI             Cont        ---           ---
  Onder (2005) [74](#jcsm12502-bib-0074){ref-type="ref"}               WHAS               CD         USA             884    78.7 ± 8.0                                            100     3 y    Own Q              ≥1 loss     ---           ---
  Ostir (1998) [75](#jcsm12502-bib-0075){ref-type="ref"}               EPESE              CD         USA             1342   73.3                                                  53.0    2 y    Own Q              ≥1 loss     ---           ---
  Peel (2014) [76](#jcsm12502-bib-0076){ref-type="ref"}                ---                TCP        AUS             351    79.0 ± 8.8                                            65.8    6 m    interRAC HC        ≥1 loss     ---           ---
  Pisters (2012) [77](#jcsm12502-bib-0077){ref-type="ref"}             ---                IP         NLD             216    66.1 ± 8.5                                            72.2    5 y    WOMAC              Cont        ---           ---
  Purser (2005) [78](#jcsm12502-bib-0078){ref-type="ref"}              VA                 IP         USA             1388   74 ± 6.0                                              2.0     1 y    Katz               Cont        LB            Cont
  Rajan (2012) [79](#jcsm12502-bib-0079){ref-type="ref"}               CNDS               CD         USA             5317   73.2 ± 6.4                                            61.0    8 y    Katz               ≥1 loss     ---           ---
  Rantanen (1999) [80](#jcsm12502-bib-0080){ref-type="ref"}            HPP, HAAS          CD         USA             6089   54.0 ± 5.5                                            0       25 y   Own Q              ≥1 loss     ---           ---
  Rantanen (2002) [81](#jcsm12502-bib-0081){ref-type="ref"}            NORA75             CD         DNK, SWE, FIN   567    75+, NR                                               60.0    5 y    Own Q              ≥1 loss     ---           ---
  Rodriguez‐Pascual (2017) [82](#jcsm12502-bib-0082){ref-type="ref"}   ---                PD, HF     ESP             497    85.2 ± 7.3                                            61.0    1 y    Katz               ≥1 loss     ---           ---
  Rothman (2008) [83](#jcsm12502-bib-0083){ref-type="ref"}             PEP                CD         USA             754    78.4 ± 5.3                                            64.6    8 y    Own Q              ≥1 loss     ---           ---
  Sakamoto (2016) [84](#jcsm12502-bib-0084){ref-type="ref"}            TLAS               CD         JPN             188    80.2 ± 3.9[a](#jcsm12502-note-0003){ref-type="fn"}    65.4    2 y    Own Q              ≥1 loss     ---           ---
  Sanchez‐Martinez (2016) [85](#jcsm12502-bib-0085){ref-type="ref"}    Penagrade cohort   CD         ESP             607    77.0 ± 7.6                                            50.9    4 y    Own Q              ≥1 loss     ---           ---
  Sanchez‐Rodrigeuz (2014) [86](#jcsm12502-bib-0086){ref-type="ref"}   ---                IP         ESP             99     84.6 ± 6.6                                            61.6    3 m    BI                 Cont        ---           ---
  Sarkisian (2000) [87](#jcsm12502-bib-0087){ref-type="ref"}           SOF                CD         USA             6632   73.0 ± 4.9                                            100     4 y    Own Q              ≥1 loss     Own Q         ≥1 loss
  Sarkisian (2001) [88](#jcsm12502-bib-0088){ref-type="ref"}           SOF                CD         USA             89     72.4 ± 4.5[a](#jcsm12502-note-0003){ref-type="fn"}    100     4 y    NHIS               ≥1 loss     ---           ---
  Schoenenberg (2013) [89](#jcsm12502-bib-0089){ref-type="ref"}        ---                IP, TAVI   CHE             119    83.4 ± 4.6                                            55.5    6 m    Katz               ≥1 loss     LB            ≥1 loss
  Seidel (2011) [90](#jcsm12502-bib-0090){ref-type="ref"}              SHARE              CD         EU              6841   72 ± 6.0                                              52.5    2 y    ---                ---         Own Q         ≥1 loss
  Shimada (2010) [91](#jcsm12502-bib-0091){ref-type="ref"}             E‐SAS project      CD         JPN             436    79.2 ± 6.8                                            72.5    1 y    ---                ---         TMIG IC       ≥1 loss
  Shimada (2015) [92](#jcsm12502-bib-0092){ref-type="ref"}             OSHPE              CD         JPN             4081   71.7 ± 5.3                                            51.6    2 y    LTIC               ≥1 loss     ---           ---
  Shinkai (2000) [93](#jcsm12502-bib-0093){ref-type="ref"}             TMIG‐LISA          CD         JPN             748    NR                                                    NR      6 y    Own Q              ≥1 loss     ---           ---
  Shinkai (2003) [94](#jcsm12502-bib-0094){ref-type="ref"}             TMIG‐LISA          CD         JPN             601    73.0 ± 5.3                                            65      4 y    Own Q              ≥1 loss     TMIG IC       ≥1 loss
  Sourdet (2012) [95](#jcsm12502-bib-0095){ref-type="ref"}             REAL.FR            CD, AD     FRA             632    77.8 ± 7.0[a](#jcsm12502-note-0003){ref-type="fn"}    72.2    2 y    M Katz             ≥0.5 loss   ---           ---
  Stenholm (2014) [96](#jcsm12502-bib-0096){ref-type="ref"}            InCHIANTI          CD         ITA             724    67.1 ± 15.0[a](#jcsm12502-note-0003){ref-type="fn"}   54.3    9 y    Own Q              ≥1 loss     ---           ---
  Taekema (2010) [18](#jcsm12502-bib-0018){ref-type="ref"}             Leiden 85‐plus     CD         NLD             555    NR                                                    65.0    NR     GARS               ≥1 loss     GARS          ≥1 loss
  Takuhiro (2017) [97](#jcsm12502-bib-0097){ref-type="ref"}            Hizen‐Oshima       CD         JPN             104    69.3 ± 3.0                                            100     9 y    Composite          ≥3 loss     ---           ---
  Tanimoto (2013) [98](#jcsm12502-bib-0098){ref-type="ref"}            ---                CD         JPN             716    73.2 ± 6.1[a](#jcsm12502-note-0003){ref-type="fn"}    65.8    2 y    M Katz             ≥1 loss     ---           ---
  Terhorst (2017) [99](#jcsm12502-bib-0099){ref-type="ref"}            ---                OP         USA             256    78.9 ± 5.1                                            100     6 m    PASS               ≥1 loss     PASS          ≥1 loss
  Tinetti (2005) [100](#jcsm12502-bib-0100){ref-type="ref"}            PEP, PS            CD         USA             1471   78.8 ± 5.2[a](#jcsm12502-note-0003){ref-type="fn"}    70.8    3 y    ---                ---         LB            ≥1 loss
  Volpato (2011) [101](#jcsm12502-bib-0101){ref-type="ref"}            ---                IP         ITA             87     77.4 ± 6.5[a](#jcsm12502-note-0003){ref-type="fn"}    49.0    3 m    Own Q              Cont        M LB          Cont
  Wennie Huang (2010) [102](#jcsm12502-bib-0102){ref-type="ref"}       ---                CD         USA             110    80.3 ± 7.0                                            70.9    18 m   NHIS               ≥1 loss     ---           ---
  Zhang (2013) [103](#jcsm12502-bib-0103){ref-type="ref"}              InCHIANTI          CD         ITA             562    71.4 ± 5.7                                            47.9    3 y    Own Q              ≥1 loss     Own Q         ≥1 loss
  Zoico (2007) [104](#jcsm12502-bib-0104){ref-type="ref"}              ---                CD         ITA             145    71.7 ± 2.3[a](#jcsm12502-note-0003){ref-type="fn"}    58.6    2 y    Composite          ≥1 loss     ---           ---

*Cohort*: 3C, Three City Study; BFc80+, BELFRAIL; Boston RISE, Boston Rehabilitative Impairment Study of the Elderly; CHAMP, The Concord Health and Ageing in Men Project; CHS, Cardiovascular Health Study; CNDS, Chicago Neighbourhood and Disability Study; Coyoacan, Mexica Study of Nutritional and Psychosocial Markers of Frailty among Community‐dwelling Elderly; EPESE, Established Populations for the Epidemiological Study for the Elderly; EPIDOS, epidemiology of osteoporosis; E‐SAS project, Elderly Status Assessment Set; FINE, Finland, Italy, Netherlands Elderly; GLAS, Groningen Longitudinal Ageing Study; HAAS, Honolulu Asia Aging Study; HEPESE, Hispanic Established Populations for the Epidemiological Study for the Elderly; HPP, Honolulu Heart Program; HRS, Health and Retirement Study; ICARe Dicomano, Insufficienza Cardiaca negi Anziani Residenti a Dicomano; InCHIANTI, Invecchiare in Chianti; ISCOPE, Integrated Systematic Care for Older People; LASA, Longitudinal Aging Study Amsterdam; NMAPS, New Mexico Aging Process Study; NORA75, Nordic Research on Aging 75 study; OSHPE, Obu Study of Health Promotion for the Elderly; PEP, Precipitating Events Project; PS, Project Safety; PVC, PharmacosurVeillance in the elderly Care; REAL.FR, Reseau sur la maladie Alzheimer Francais; SABE, Saude, Bem‐Estar e Envelhecimento; SITE, Sources of Independence in the Elderly; SHARE, The Survey of Health, Ageing and Retirement in Europe; SNAC‐K, Swedish National study on Aging and Care in Kungsholemn; SOF, Study of Osteoporotic Fractures; TILDA, The Irish Longitudinal Study of Ageing; LISA, Longitudinal Interdisciplinary Study on Aging; TLAS, Tosa Longitudinal Aging Study; TMIG‐LISA, Tokyo Metropolitan Institute of Gerontology Longitudinal Interdisciplinary Study on Ageing; VA, Department of Veterans Affairs; WHAS, Women\'s Health and Aging Study. *Setting*: AD, Alzheimer\'s disease; CD, community‐dwelling; OP, outpatients; IP, inpatients; TAVI, transcatheter aortic valve implantation; TCP, transitional care program; PB, population based; PD, post‐discharge; HF, heart failure. *Country*: AUS, Australia; BEL, Belgium; BRA, Brazil; CHE, Switzerland; DEU, Germany; DNK, Denmark; ESP, Spain; EU, Europe; FIN, Finland; FRA, France; HKG, Hong Kong; IRL, Ireland; ISR, Israel; ITA, Italy; JPN, Japan; KOR, Korea; MEX, Mexico; NLD, Netherlands; NOR, Norway; POL, Poland; SWE, Sweden; USA, United States. *Age*: presented as mean ± SD or median (range) or (IQR); range, percentage; ---, not applicable or reported; F, female; FU, follow‐up duration; D, day(s); M, month(s); Y, year(s). *ADL*: ---, not applicable or reported; BI, Barthel Index; Cont, continuous; GARS, Groningen Activities Restriction Scale; HAQ, Stanford Health Assessment Questionnaire; interRAC HC, interRAC Home Care; Nor BI, Norwegian Barthel Index; M A PADL‐H scale, modified Avlund Physical ADL‐H scale; M Katz, modified Katz Index; M BI, modified Barthel Index; M WHO, modified World Health Organization scale; LLFDI‐FC, Functional Component of the Late‐Life Function and Disability Instrument; LTCI, long‐term care insurance system; PASS, Performance Assessment of Self‐Care Skills; WHO, World Health Organization; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index. *IADL*: ---, not applicable or reported; AMPS, assessment of motor and process skills; GARS, Groningen Activities Restriction Scale; KIADL, Korean IADL; LB, Lawton and Brody; M LB, modified Lawton and Brody; M WHO, modified WHO scale; NHIS, National Health Interview Survey; OARS, Older Americans Resources and Services; RB, Rosow‐Breslau scale; TMIG‐IC, Tokyo Metropolitan Institute of Gerontology Index of Competence.

Calculated mean ± SD or mean from information provided.

Qualitative analysis {#jcsm12502-sec-0010}
--------------------

Muscle mass was reported in 13 articles,[28](#jcsm12502-bib-0028){ref-type="ref"}, [32](#jcsm12502-bib-0032){ref-type="ref"}, [35](#jcsm12502-bib-0035){ref-type="ref"}, [36](#jcsm12502-bib-0036){ref-type="ref"}, [37](#jcsm12502-bib-0037){ref-type="ref"}, [38](#jcsm12502-bib-0038){ref-type="ref"}, [50](#jcsm12502-bib-0050){ref-type="ref"}, [59](#jcsm12502-bib-0059){ref-type="ref"}, [60](#jcsm12502-bib-0060){ref-type="ref"}, [65](#jcsm12502-bib-0065){ref-type="ref"}, [86](#jcsm12502-bib-0086){ref-type="ref"}, [98](#jcsm12502-bib-0098){ref-type="ref"}, [104](#jcsm12502-bib-0104){ref-type="ref"} six using dual‐energy X‐ray absorptiometry, five using bioelectrical impedance analysis, one using computed tomography, and one did not report the measurement method (*Table* [2](#jcsm12502-tbl-0002){ref-type="table"}). Low muscle mass was positively associated with worsening ADL in 5/9 articles and IADL in 5/5 at follow‐up.

###### 

Muscle mass as predictor of activities of daily living or instrumental activities of daily living

  First author (year) \[ref\]                                          *N*    Tool   Measure          Units                                              Cut‐offs                                           AM   MA
  -------------------------------------------------------------------- ------ ------ ---------------- -------------------------------------------------- -------------------------------------------------- ---- ----
  Amigues (2013) [28](#jcsm12502-bib-0028){ref-type="ref"}             975    DXA    SMI              kg/m^2^                                            SD (NR)                                            A    Y
                                                                                                      Quartile[a](#jcsm12502-note-0005){ref-type="fn"}   A                                                  N    
  975                                                                  DXA    LM     kg               SD (NR)                                            A                                                  N    
  Baumgartner (2004) [32](#jcsm12502-bib-0032){ref-type="ref"}         451    DXA    SMI              kg/m^2^                                            M: 7.26. F: 5.45                                   A    N
  Bianchi (2015) [35](#jcsm12502-bib-0035){ref-type="ref"}             538    BIA    SMI              kg/m^2^                                            M: 8.87. F: 6.42                                   A    Y
  Broadwin (2001) [36](#jcsm12502-bib-0036){ref-type="ref"}            1051   BIA    FFM              \%                                                 Quintile[b](#jcsm12502-note-0006){ref-type="fn"}   A    N
  Carriere (2005) [37](#jcsm12502-bib-0037){ref-type="ref"}            545    ---    LM/BM            ---                                                \<0.54, 0.54--0.63, ≥0.63                          A    N
  Cesari (2015) [38](#jcsm12502-bib-0038){ref-type="ref"}              991    CT     Muscle density   mg/cm^3^                                           SD (M: 3.32. F: 3.60)                              A    N
  Fantin (2007) [50](#jcsm12502-bib-0050){ref-type="ref"}              159    DXA    FFM              kg                                                 Continuous                                         U    N
  Hirani (2015) [59](#jcsm12502-bib-0059){ref-type="ref"}              1819   DXA    ALM              kg                                                 \<19.75                                            A    N
  Hirani (2017) [60](#jcsm12502-bib-0060){ref-type="ref"}              1685   DXA    ALM/BMI          ---                                                \<0.789                                            A    Y
  Janssen (2006) [65](#jcsm12502-bib-0065){ref-type="ref"}             3694   BIA    MM               kg                                                 Quartile (NR)                                      A    N
  3694                                                                 BIA    SMI    kg/m^2^          M: \<10.75. F: \<6.75                              A                                                  Y    
  Sanchez‐Rodrigeuz (2014) [86](#jcsm12502-bib-0086){ref-type="ref"}   99     BIA    FFM              kg                                                 Continuous                                         A    N
  99                                                                   BIA    LBM    kg               Continuous                                         A                                                  N    
  Tanimoto (2013) [98](#jcsm12502-bib-0098){ref-type="ref"}            716    BIA    AMI              kg/m^2^                                            M: \<7.0. F: \<5.8                                 U    Y
  Zoico (2007) [104](#jcsm12502-bib-0104){ref-type="ref"}              145    DXA    AMI              kg/m^2^                                            \<7.6                                              A    N

*Measure*: ---, not applicable or reported; ALM, appendicular lean mass; AMI, appendicular mass index; BIA, bioelectrical impedance analysis; BM, body mass; CT, computed tomography; DXA, dual‐energy X‐ray absorptiometry; FFM, fat free mass; LBM, lean body mass; LM, lean mass; MM, muscle mass; SMI, skeletal muscle index. *Cut‐off*: NR, not reported; SD, standard deviation. Expressed as either dichotomous, ranges for specific tertiles, quartiles, quintiles, or categories or per unit or score. AM, adjustment model denotes whether the model in the meta‐analysis was: A, adjusted; or U, unadjusted. MA, meta‐analysis; N, no; Y, yes.

≥6.72, 6.30--6.72, 5.82--6.30, \<5.82.

M: 35.5--75.6, 75.7--78.0, 78.1--80.2, 80.3--82.8, 82.9--93.0. F: 45.6--67.0, 67.1--69.4, 69.5--71.8, 71.9--74.7, 74.8--88.0.

###### 

Muscle strength as predictor of activities of daily living or instrumental activities of daily living

  First author (year) \[ref\]                                          *N*    Measure   Units                                              Cut‐offs                                               AM   MA
  -------------------------------------------------------------------- ------ --------- -------------------------------------------------- ------------------------------------------------------ ---- ----
  Abete (2017) [24](#jcsm12502-bib-0024){ref-type="ref"}               907    HGS       NR                                                 Dich (NR)                                              A    Y
  907                                                                  SS     NR        Dich (NR)                                          A                                                      N    
  Al snih (2004) [25](#jcsm12502-bib-0025){ref-type="ref"}             2493   HGS       kg                                                 Continuous                                             U    Y
                                                                                        Quartile[a](#jcsm12502-note-0008){ref-type="fn"}   U                                                      Y    
  Alexandre (2012) [27](#jcsm12502-bib-0027){ref-type="ref"}           1634   HGS       kg                                                 Continuous                                             A    Y
  Amigues (2013) [28](#jcsm12502-bib-0028){ref-type="ref"}             975    HGS       kPa                                                SD (NR)                                                A    N
  Beloosesky (2009) [34](#jcsm12502-bib-0034){ref-type="ref"}          93     HGS       kg                                                 Continuous                                             U    N
  Bianchi (2015) [35](#jcsm12502-bib-0035){ref-type="ref"}             538    HGS       kg                                                 BMI specific[b](#jcsm12502-note-0009){ref-type="fn"}   A    N
  Carriere (2005) [37](#jcsm12502-bib-0037){ref-type="ref"}            545    HGS       kPa                                                \<47                                                   A    Y
  545                                                                  QS     N/cm      \<3.52, 3.52--4.95, ≥4.95                          A                                                      N    
  Cesari (2015) [38](#jcsm12502-bib-0038){ref-type="ref"}              991    HGS       kg                                                 SD (M: 10.11. F: 7.49)                                 A    N
  991                                                                  AE     kg        SD (M: 9.79. F: 8.35)                              A                                                      N    
  Chan (2014) [39](#jcsm12502-bib-0039){ref-type="ref"}                570    HGS       kg                                                 Continuous                                             A    N
  570                                                                  QS     kg        Continuous                                         A                                                      N    
  Chaudhry (2010) [40](#jcsm12502-bib-0040){ref-type="ref"}            5888   HGS       kg                                                 Lowest quintile for sex and BMI (NR)                   A    Y
  Costanzo (2018) [44](#jcsm12502-bib-0044){ref-type="ref"}            709    HGS       ---                                                Lowest quintile for sex and BMI (NR)                   U    Y
  Den Ouden (2013) [45](#jcsm12502-bib-0045){ref-type="ref"}           625    HGS       kg                                                 Per 10                                                 A    N
  625                                                                  QS     Nm        Per 10                                             A                                                      N    
  Di Monaco (2015) [47](#jcsm12502-bib-0047){ref-type="ref"}           193    HGS       kg                                                 SD (5.7)                                               A    N
  Duchowny (2018) [49](#jcsm12502-bib-0049){ref-type="ref"}            8467   HGS       kg                                                 WM: \<35, BM: \<40, WW: \<22, BW: \<31                 A    Y
  Femia (1997) [51](#jcsm12502-bib-0051){ref-type="ref"}               95     HGS       kPa                                                Continuous                                             U    N
  Giampaoli (1999) [53](#jcsm12502-bib-0053){ref-type="ref"}           140    HGS       kPa                                                Continuous                                             A    N
  Gill (2009) [55](#jcsm12502-bib-0055){ref-type="ref"}                722    HGS       kg                                                 BMI specific[c](#jcsm12502-note-0010){ref-type="fn"}   A    Y
  Hirani (2015) [59](#jcsm12502-bib-0059){ref-type="ref"}              1819   HGS       kg                                                 \<26                                                   A    N
  Ishizaki (2000) [64](#jcsm12502-bib-0064){ref-type="ref"}            468    HGS       kg                                                 Continuous                                             A    Y
  Kozicka (2016) [67](#jcsm12502-bib-0067){ref-type="ref"}             41     HGS       kg                                                 Continuous                                             U    N
  Kwon (2012) [68](#jcsm12502-bib-0068){ref-type="ref"}                204    HGS       kg                                                 BMI specific[d](#jcsm12502-note-0011){ref-type="fn"}   A    N
  Legrand (2014) [69](#jcsm12502-bib-0069){ref-type="ref"}             309    HGS       kg                                                 Tertile[e](#jcsm12502-note-0012){ref-type="fn"}        A    Y
  Lopez‐Teros (2014) [70](#jcsm12502-bib-0070){ref-type="ref"}         133    HGS       kg                                                 Continuous                                             A    N
  McGrath (2018) [71](#jcsm12502-bib-0071){ref-type="ref"}             672    HGS       kg                                                 Continuous                                             A    N
  Minneci (2015) [72](#jcsm12502-bib-0072){ref-type="ref"}             453    HGS       kg                                                 Continuous                                             A    Y
  Moen (2018) [73](#jcsm12502-bib-0073){ref-type="ref"}                115    HGS       kg                                                 Continuous                                             A    N
  Onder (2005) [74](#jcsm12502-bib-0074){ref-type="ref"}               458    HGS       kg                                                 SD (5.9)                                               A    N
  Pisters (2012) [77](#jcsm12502-bib-0077){ref-type="ref"}             216    KE        N/kg                                               SD (0.6)                                               A    N
  Rantanen (1999) [80](#jcsm12502-bib-0080){ref-type="ref"}            6089   HGS       kg                                                 Tertile[f](#jcsm12502-note-0013){ref-type="fn"}        A    N
  Rantanen (2002) [81](#jcsm12502-bib-0081){ref-type="ref"}            553    HGS       N                                                  M: \<392. F: \<225                                     U    Y
  554                                                                  AF     N         M: \<274, \<348. F: \<159, \<198                   A                                                      N    
  550                                                                  KE     N         M: \<363, \<449. F: \<225, \<287                   A                                                      N    
  546                                                                  TE     N         M: \<542, \<631. F: \<271, \<393                   A                                                      N    
  538                                                                  TF     N         M: \<472, \<571. F: \<231, \<330                   A                                                      N    
  Rodriguez‐Pascual (2017) [82](#jcsm12502-bib-0082){ref-type="ref"}   277    HGS       kg                                                 Lowest quintile for sex and BMI (NR)                   A    Y
  Rothman (2008) [83](#jcsm12502-bib-0083){ref-type="ref"}             754    HGS       kg                                                 BMI specific[g](#jcsm12502-note-0014){ref-type="fn"}   A    Y
  Sanchez‐Rodrigeuz (2014) [86](#jcsm12502-bib-0086){ref-type="ref"}   99     HGS       kg                                                 Continuous                                             U    N
  Sarkisian (2000) [87](#jcsm12502-bib-0087){ref-type="ref"}           6632   HGS       kg                                                 Lowest Quintile (NR)                                   A    Y
  Sarkisian (2001) [88](#jcsm12502-bib-0088){ref-type="ref"}           89     HGS       kg                                                 Decile (NR)                                            A    N
  Seidel (2011) [90](#jcsm12502-bib-0090){ref-type="ref"}              6670   HGS       kg                                                 \<26                                                   U    Y
  Shinkai (2000) [93](#jcsm12502-bib-0093){ref-type="ref"}             513    HGS       kg                                                 Age specific[h](#jcsm12502-note-0015){ref-type="fn"}   U    Y
  Shinkai (2003) [94](#jcsm12502-bib-0094){ref-type="ref"}             601    HGS       kg                                                 Quartile decrease                                      A    Y
  Taekema (2010) [18](#jcsm12502-bib-0018){ref-type="ref"}             555    HGS       kg                                                 Continuous                                             A    N
  Tanimoto (2013) [98](#jcsm12502-bib-0098){ref-type="ref"}            716    HGS       kg                                                 Lowest quartile (NR)                                   U    N
  Wennie Huang (2010) [102](#jcsm12502-bib-0102){ref-type="ref"}       65     HGS       kg                                                 Continuous                                             A    Y

*Measure*: ---: not applicable or reported; AE, ankle extension; AF, arm flexion; BMI, body mass index; HGS, handgrip strength; KE, knee extension; QS, quadriceps strength; SS, shoulder strength; TE, trunk extension; TF, trunk flexion. *Cut‐offs*: NR, not reported; SD, standard deviation. Expressed as either dichotomous, ranges for specific tertiles, quartiles, quintiles, or categories or per unit or score. AM, adjustment model denotes whether the model in the meta‐analysis was: A, adjusted; or U, unadjusted. MA, meta‐analysis; N, no; Y, yes.

M: \<22.00, 21.01--30.00, 30.01--35.00, ≥35.01. F: \<14.00, 14.01--18.20, 18.21--22.50, ≥22.51.

M: ≤24: ≤29, 24.1--28: ≤30, \>30: ≤32. F: ≤23: ≤17, 23.1--26: ≤17.3, 26.1--29: ≤21.

M: ≤24: ≤29, 24.1--26: ≤30, 26.1--28: ≤30, \>28: ≤32. F: ≤23: ≤17, 23.1--26: ≤17.3, 26.1--29: ≤18, \>29: ≤21.

M: \<25, 25.0--29.9, 30.0--39.9, \>40. F: \<15, 15.0--19.9, 20.0--24.9, \>25.

M: \<25.3, 25.4--33.2, \>33.3. F: \<15.0, 15.1--20.0, \>20.1.

\<37.0, 37.0--42.0, \>42.0.

M: ≤24: ≤29, 24.1--26: ≤30, 26.1--28: ≤30, \>28: ≤32. F: ≤23: ≤17, 23.1--26: ≤17.3, 26.1--29: ≤18, \>29: ≤21.

M: 65--74: \<37, ≥75: \<30. F: 65--74: \<22, ≥75: \<20.

Muscle strength was investigated in 41[18](#jcsm12502-bib-0018){ref-type="ref"}, [24](#jcsm12502-bib-0024){ref-type="ref"}, [25](#jcsm12502-bib-0025){ref-type="ref"}, [27](#jcsm12502-bib-0027){ref-type="ref"}, [28](#jcsm12502-bib-0028){ref-type="ref"}, [34](#jcsm12502-bib-0034){ref-type="ref"}, [35](#jcsm12502-bib-0035){ref-type="ref"}, [37](#jcsm12502-bib-0037){ref-type="ref"}, [38](#jcsm12502-bib-0038){ref-type="ref"}, [39](#jcsm12502-bib-0039){ref-type="ref"}, [40](#jcsm12502-bib-0040){ref-type="ref"}, [44](#jcsm12502-bib-0044){ref-type="ref"}, [45](#jcsm12502-bib-0045){ref-type="ref"}, [47](#jcsm12502-bib-0047){ref-type="ref"}, [49](#jcsm12502-bib-0049){ref-type="ref"}, [51](#jcsm12502-bib-0051){ref-type="ref"}, [53](#jcsm12502-bib-0053){ref-type="ref"}, [55](#jcsm12502-bib-0055){ref-type="ref"}, [59](#jcsm12502-bib-0059){ref-type="ref"}, [64](#jcsm12502-bib-0064){ref-type="ref"}, [67](#jcsm12502-bib-0067){ref-type="ref"}, [68](#jcsm12502-bib-0068){ref-type="ref"}, [69](#jcsm12502-bib-0069){ref-type="ref"}, [70](#jcsm12502-bib-0070){ref-type="ref"}, [71](#jcsm12502-bib-0071){ref-type="ref"}, [72](#jcsm12502-bib-0072){ref-type="ref"}, [73](#jcsm12502-bib-0073){ref-type="ref"}, [74](#jcsm12502-bib-0074){ref-type="ref"}, [77](#jcsm12502-bib-0077){ref-type="ref"}, [80](#jcsm12502-bib-0080){ref-type="ref"}, [81](#jcsm12502-bib-0081){ref-type="ref"}, [82](#jcsm12502-bib-0082){ref-type="ref"}, [83](#jcsm12502-bib-0083){ref-type="ref"}, [86](#jcsm12502-bib-0086){ref-type="ref"}, [87](#jcsm12502-bib-0087){ref-type="ref"}, [88](#jcsm12502-bib-0088){ref-type="ref"}, [90](#jcsm12502-bib-0090){ref-type="ref"}, [93](#jcsm12502-bib-0093){ref-type="ref"}, [94](#jcsm12502-bib-0094){ref-type="ref"}, [98](#jcsm12502-bib-0098){ref-type="ref"}, [102](#jcsm12502-bib-0102){ref-type="ref"} articles as a predictor of ADL and IADL (*Table* [3](#jcsm12502-tbl-0003){ref-type="table"}). Handgrip strength was used as a measure of muscle strength in 40 articles, five using quadriceps or knee strength and each of the following were used in single articles: shoulder strength, ankle and torso flexion, and extension. Low muscle strength was positively associated with worsening ADL in 22/34 and IADL in 8/9 at follow‐up.

A total of 62 articles[16](#jcsm12502-bib-0016){ref-type="ref"}, [26](#jcsm12502-bib-0026){ref-type="ref"}, [27](#jcsm12502-bib-0027){ref-type="ref"}, [28](#jcsm12502-bib-0028){ref-type="ref"}, [29](#jcsm12502-bib-0029){ref-type="ref"}, [30](#jcsm12502-bib-0030){ref-type="ref"}, [31](#jcsm12502-bib-0031){ref-type="ref"}, [33](#jcsm12502-bib-0033){ref-type="ref"}, [35](#jcsm12502-bib-0035){ref-type="ref"}, [37](#jcsm12502-bib-0037){ref-type="ref"}, [38](#jcsm12502-bib-0038){ref-type="ref"}, [40](#jcsm12502-bib-0040){ref-type="ref"}, [41](#jcsm12502-bib-0041){ref-type="ref"}, [42](#jcsm12502-bib-0042){ref-type="ref"}, [43](#jcsm12502-bib-0043){ref-type="ref"}, [44](#jcsm12502-bib-0044){ref-type="ref"}, [45](#jcsm12502-bib-0045){ref-type="ref"}, [46](#jcsm12502-bib-0046){ref-type="ref"}, [48](#jcsm12502-bib-0048){ref-type="ref"}, [49](#jcsm12502-bib-0049){ref-type="ref"}, [52](#jcsm12502-bib-0052){ref-type="ref"}, [54](#jcsm12502-bib-0054){ref-type="ref"}, [55](#jcsm12502-bib-0055){ref-type="ref"}, [56](#jcsm12502-bib-0056){ref-type="ref"}, [57](#jcsm12502-bib-0057){ref-type="ref"}, [58](#jcsm12502-bib-0058){ref-type="ref"}, [59](#jcsm12502-bib-0059){ref-type="ref"}, [61](#jcsm12502-bib-0061){ref-type="ref"}, [62](#jcsm12502-bib-0062){ref-type="ref"}, [63](#jcsm12502-bib-0063){ref-type="ref"}, [66](#jcsm12502-bib-0066){ref-type="ref"}, [68](#jcsm12502-bib-0068){ref-type="ref"}, [69](#jcsm12502-bib-0069){ref-type="ref"}, [70](#jcsm12502-bib-0070){ref-type="ref"}, [71](#jcsm12502-bib-0071){ref-type="ref"}, [72](#jcsm12502-bib-0072){ref-type="ref"}, [73](#jcsm12502-bib-0073){ref-type="ref"}, [74](#jcsm12502-bib-0074){ref-type="ref"}, [75](#jcsm12502-bib-0075){ref-type="ref"}, [76](#jcsm12502-bib-0076){ref-type="ref"}, [78](#jcsm12502-bib-0078){ref-type="ref"}, [79](#jcsm12502-bib-0079){ref-type="ref"}, [82](#jcsm12502-bib-0082){ref-type="ref"}, [83](#jcsm12502-bib-0083){ref-type="ref"}, [84](#jcsm12502-bib-0084){ref-type="ref"}, [85](#jcsm12502-bib-0085){ref-type="ref"}, [87](#jcsm12502-bib-0087){ref-type="ref"}, [89](#jcsm12502-bib-0089){ref-type="ref"}, [90](#jcsm12502-bib-0090){ref-type="ref"}, [91](#jcsm12502-bib-0091){ref-type="ref"}, [92](#jcsm12502-bib-0092){ref-type="ref"}, [93](#jcsm12502-bib-0093){ref-type="ref"}, [94](#jcsm12502-bib-0094){ref-type="ref"}, [95](#jcsm12502-bib-0095){ref-type="ref"}, [96](#jcsm12502-bib-0096){ref-type="ref"}, [97](#jcsm12502-bib-0097){ref-type="ref"}, [98](#jcsm12502-bib-0098){ref-type="ref"}, [99](#jcsm12502-bib-0099){ref-type="ref"}, [100](#jcsm12502-bib-0100){ref-type="ref"}, [101](#jcsm12502-bib-0101){ref-type="ref"}, [102](#jcsm12502-bib-0102){ref-type="ref"}, [103](#jcsm12502-bib-0103){ref-type="ref"} reported physical performance as a predictor of ADL and IADL (*Table* [4](#jcsm12502-tbl-0004){ref-type="table"}). Gait speed was the most reported measure, with a total of 37 articles, followed by the composite test short physical performance battery (SPPB), which was reported in 14 articles. Other measures of physical performance included a variety of balance (*n* = 15), chair stand (*n* = 10), timed up and go (*n* = 8), and functional reach tests (*n* = 2) as well as tests that involve multiple assessments (*n* = 3). Poor physical performance was positively associated with worsening ADL in 37/49 articles and IADL in 9/11 at follow‐up: SPPB (10/13, 2/2), gait speed (27/33, 7/8), one leg balance (3/4, 0/0), and chair stand test (4/9, 0/1).

###### 

Physical performance as predictor of activities of daily living or instrumental activities of daily living

  First author (year) \[ref\]                                          *N*                Measure           Units                                                                    Cut‐offs                                           AM   MA
  -------------------------------------------------------------------- ------------------ ----------------- ------------------------------------------------------------------------ -------------------------------------------------- ---- ----
  Albert (2015) [26](#jcsm12502-bib-0026){ref-type="ref"}              347                Gait              m/s                                                                      Quartile[a](#jcsm12502-note-0017){ref-type="fn"}   A    N
  Alexandre (2012) [27](#jcsm12502-bib-0027){ref-type="ref"}           1634               OLB               s                                                                        Continuous                                         A    N
  1634                                                                 CST                s                 Continuous                                                               A                                                  N    
  Amigues (2013) [28](#jcsm12502-bib-0028){ref-type="ref"}             975                Gait              m/s                                                                      SD (0.22)                                          A    N
  974                                                                  Balance            s                 Tertile[b](#jcsm12502-note-0018){ref-type="fn"}                          A                                                  N    
  Arnau (2016) [29](#jcsm12502-bib-0029){ref-type="ref"}               252                SPPB              points                                                                   \<7                                                U    Y
  Artaud (2015) [30](#jcsm12502-bib-0030){ref-type="ref"}              3814               Fast Gait         m/s                                                                      SD (0.22)                                          A    N
  3814                                                                 Change in FG       m/s               SD (0.013)                                                               A                                                  N    
  Basic (2017) [31](#jcsm12502-bib-0031){ref-type="ref"}               1693               TUG               s                                                                        Continuous                                         U    N
  Beauchamp (2015) [33](#jcsm12502-bib-0033){ref-type="ref"}           430                SPPB              points                                                                   Continuous                                         U    N
  430                                                                  Gait               m/s               Continuous (0.1)                                                         U                                                  N    
  428                                                                  400 m walk         min               Continuous                                                               U                                                  N    
  413                                                                  Stair climb        watts             Continuous                                                               U                                                  N    
  Bianchi (2015) [35](#jcsm12502-bib-0035){ref-type="ref"}             538                Gait              m/s                                                                      \<0.8                                              A    N
  Carriere (2005) [37](#jcsm12502-bib-0037){ref-type="ref"}            545                Gait              m/s                                                                      \<0.78                                             A    Y
  545                                                                  Standing balance   ---               Tertile[c](#jcsm12502-note-0019){ref-type="fn"}                          A                                                  N    
  545                                                                  Dynamic balance    ---               Cat (3)                                                                  A                                                  N    
  545                                                                  CST                s                 \<13 s                                                                   A                                                  Y    
  545                                                                  Foot tapping       ---               Tertile                                                                  A                                                  N    
  Cesari (2015) [38](#jcsm12502-bib-0038){ref-type="ref"}              991                Gait              m/s                                                                      SD (M: 0.24. F: 0.23)                              A    Y
  Chaudhry (2010) [40](#jcsm12502-bib-0040){ref-type="ref"}            5888               Gait              m/s                                                                      Lowest quintile for sex and height (NR)            A    Y
  Chu (2006) [41](#jcsm12502-bib-0041){ref-type="ref"}                 1338               Gait              m/s                                                                      \<0.65 m/s                                         A    Y
  Cooper (2011) [42](#jcsm12502-bib-0042){ref-type="ref"}              1425               Timed walk test   ---                                                                      Continuous                                         A    N
  1425                                                                 Tandem stand       ---                                                                                        A                                                  N    
  1425                                                                 Cardigan test      s                                                                                          A                                                  N    
  1425                                                                 CST                s                                                                                          A                                                  N    
  Corsonello (2012) [43](#jcsm12502-bib-0043){ref-type="ref"}          506                SPPB              points                                                                   Continuous                                         A    Y
                                                                                                            \<9                                                                      U                                                  Y    
  Costanzo (2018) [44](#jcsm12502-bib-0044){ref-type="ref"}            709                Gait              m/s                                                                      Lowest quintile for sex and height (NR)            U    Y
  709                                                                  Balance            s                 Lowest quintile for sex and height (NR)                                  U                                                  N    
  Den Ouden (2013) [45](#jcsm12502-bib-0045){ref-type="ref"}           625                SPPB              points                                                                   Continuous                                         A    Y
  Denkinger (2010) [46](#jcsm12502-bib-0046){ref-type="ref"}           161                Change in gait    m/s                                                                      Continuous                                         A    N
  Donoghue (2014) [48](#jcsm12502-bib-0048){ref-type="ref"}            1391               Gait              m/s                                                                      Continuous (0.1)                                   U    N
  1391                                                                 TUG                s                 Continuous                                                               U                                                  N    
  Duchowny (2018) [49](#jcsm12502-bib-0049){ref-type="ref"}            8467               Gait              m/s                                                                      \<0.8                                              A    Y
  Fujiwara (2016) [52](#jcsm12502-bib-0052){ref-type="ref"}            981                Gait              m/s                                                                      Tertile (NR)                                       A    Y
  Gill (1996) [54](#jcsm12502-bib-0054){ref-type="ref"}                775                Own test          ---                                                                      Quartile (25%)                                     U    N
  Gill (2009) [55](#jcsm12502-bib-0055){ref-type="ref"}                722                SPPB              points                                                                   Continuous                                         A    Y
  722                                                                  RGT                s                 ≤10                                                                      U                                                  N    
  722                                                                  Gait and balance   points            Continuous                                                               U                                                  N    
  722                                                                  CST                s                 Dich (NR)                                                                U                                                  Y    
  722                                                                  Chair              ---               Dich                                                                     U                                                  N    
  722                                                                  Manual dexterity   s                 Quartile[d](#jcsm12502-note-0020){ref-type="fn"}                         U                                                  N    
  722                                                                  GMC                s                 Quartile[e](#jcsm12502-note-0021){ref-type="fn"}                         U                                                  N    
  Guralnik (2000) [56](#jcsm12502-bib-0056){ref-type="ref"}            2542               SPPB              points                                                                   \<10                                               U    Y
  Hansen (1999) [57](#jcsm12502-bib-0057){ref-type="ref"}              73                 TUG               s                                                                        Tertile[f](#jcsm12502-note-0022){ref-type="fn"}    U    N
  73                                                                   Tinetti balance    points            Tertile[g](#jcsm12502-note-0023){ref-type="fn"}                          U                                                  N    
  Heiland (2016) [58](#jcsm12502-bib-0058){ref-type="ref"}             1971               Gait              m/s                                                                      \<0.8                                              A    Y
  1971                                                                 OLB                s                 \<5                                                                      A                                                  Y    
  Hirani (2015) [59](#jcsm12502-bib-0059){ref-type="ref"}              1819               Gait              m/s                                                                      ≤0.8                                               A    N
  Hoeymans (1996) [61](#jcsm12502-bib-0061){ref-type="ref"}            303                Gait              m/s                                                                      \<0.73                                             U    N
  303                                                                  CST                s                 ≤17.2                                                                    U                                                  N    
  Hong (2016) [62](#jcsm12502-bib-0062){ref-type="ref"}                8000               Gait              m/s                                                                      \<0.6                                              A    Y
  Idland (2013) [63](#jcsm12502-bib-0063){ref-type="ref"}              113                Gait              m/s                                                                      Cont (1)                                           A    Y
  113                                                                  FRT                cm                Cont (1)                                                                 A                                                  N    
  113                                                                  Step climb test    cm                Per 10                                                                   A                                                  N    
  Jonkman (2018) [16](#jcsm12502-bib-0016){ref-type="ref"}             798                Gait              m/s                                                                      Dich (NR)                                          A    N
  798                                                                  Tandem stand       s                 \<10 s                                                                   A                                                  N    
  Kempen (1998) [66](#jcsm12502-bib-0066){ref-type="ref"}              557                Walk turn walk    s                                                                        Cont                                               A    N
  557                                                                  CST                s                 Cont                                                                     A                                                  N    
  557                                                                  CST                s                 Cont                                                                     A                                                  N    
  557                                                                  Jacket             s                 Cont                                                                     A                                                  N    
  Kwon (2012) [68](#jcsm12502-bib-0068){ref-type="ref"}                204                Gait              m/s                                                                      Quartile[h](#jcsm12502-note-0024){ref-type="fn"}   A    N
  204                                                                  Balance            s                 FT10, FT1‐9, ST10, StS10                                                 A                                                  N    
  204                                                                  CST                s                 Quartile[i](#jcsm12502-note-0025){ref-type="fn"}                         A                                                  N    
  Legrand (2014) [69](#jcsm12502-bib-0069){ref-type="ref"}             308                SPPB              points                                                                   M: \<10. F: \<8                                    U    Y
  Lopez‐Teros (2014) \[54\]                                            133                Gait              m/s                                                                      Continuous (1)                                     A    Y
  McGrath (2018) [71](#jcsm12502-bib-0071){ref-type="ref"}             672                Gait              m/s                                                                      Lowest quintile for sex and height (NR)            A    Y
  Minneci (2015) [72](#jcsm12502-bib-0072){ref-type="ref"}             453                Gait              m/s                                                                      Continuous (1)                                     A    Y
  453                                                                  SPPB               points            Continuous                                                               A                                                  Y    
  453                                                                  6MWT               m                 Continuous                                                               A                                                  N    
  Moen (2018) [73](#jcsm12502-bib-0073){ref-type="ref"}                75                 TUG               s                                                                        Continuous                                         A    N
  Onder (2005) [74](#jcsm12502-bib-0074){ref-type="ref"}               458                Balance           s                                                                        SD (10.2)                                          A    N
  458                                                                  CST                s                 SD (8.4)                                                                 A                                                  N    
  458                                                                  Gait               m/s               SD (0.31)                                                                A                                                  Y    
  458                                                                  LE comp            ---               SD (0.69)                                                                A                                                  N    
  458                                                                  Blouse             s                 SD (72)                                                                  A                                                  N    
  458                                                                  Purdue             s                 SD (10.5)                                                                A                                                  N    
  458                                                                  UE comp            ---               SD (0.49)                                                                A                                                  N    
  Ostir (1998) [75](#jcsm12502-bib-0075){ref-type="ref"}               1342               SPPB              points                                                                   \<9                                                U    Y
  1328                                                                 Gait               m/s               \<0.8                                                                    U                                                  Y    
  1342                                                                 CST                s                 \<10.9                                                                   U                                                  Y    
  1006                                                                 Balance            s                 FT10, FT2‐10, StS10                                                      U                                                  N    
  Peel (2014) [76](#jcsm12502-bib-0076){ref-type="ref"}                280                Gait              m/s                                                                      Continuous (0.1)                                   A    Y
  Purser (2005) [78](#jcsm12502-bib-0078){ref-type="ref"}              1388               Gait              m/s                                                                      Continuous (0.1)                                   A    N
  1388                                                                 Change in gait     m/s               Continuous (0.1)                                                         A                                                  N    
  Rajan (2012) [79](#jcsm12502-bib-0079){ref-type="ref"}               5317               M SPPB            points                                                                   Continuous                                         A    Y
  Rodriguez‐Pascual (2017) [82](#jcsm12502-bib-0082){ref-type="ref"}   218                Gait              m/s                                                                      Lowest quintile for sex (NR)                       A    Y
  Rothman (2008) [83](#jcsm12502-bib-0083){ref-type="ref"}                                Gait              m/s                                                                      \<0.3                                              A    N
  Sakamoto (2016) [84](#jcsm12502-bib-0084){ref-type="ref"}            188                TUG               s                                                                        \<15 s                                             A    Y
  188                                                                  FRT                cm                \<20                                                                     A                                                  N    
  Sanchez‐Martinez (2016) [85](#jcsm12502-bib-0085){ref-type="ref"}    607                SPPB              points                                                                   \<8                                                A    N
  607                                                                  Gait               m/s               \<0.8                                                                    A                                                  N    
  Sarkisian (2000) [87](#jcsm12502-bib-0087){ref-type="ref"}           6632               Gait              m/s                                                                      Lowest quintile (NR)                               A    N
  Schoenenberg (2013) [89](#jcsm12502-bib-0089){ref-type="ref"}        119                TUG               s                                                                        \<20 s                                             U    Y
  Seidel (2011) [90](#jcsm12502-bib-0090){ref-type="ref"}              1804               Gait              m/s                                                                      \<0.4                                              U    Y
  Shimada (2010) [91](#jcsm12502-bib-0091){ref-type="ref"}             436                TUG               s                                                                        \<12                                               A    Y
  Shimada (2015) [92](#jcsm12502-bib-0092){ref-type="ref"}             4081               Gait              ---                                                                      \<1.0                                              A    N
  Shinkai (2000) [93](#jcsm12502-bib-0093){ref-type="ref"}             513                UWS               m/s                                                                      Tertile[j](#jcsm12502-note-0026){ref-type="fn"}    U    Y
  513                                                                  MWS                m/s               Age and sex specific quartiles[k](#jcsm12502-note-0027){ref-type="fn"}   A                                                  N    
  513                                                                  OLB                s                 Tertile[l](#jcsm12502-note-0028){ref-type="fn"}                          U                                                  Y    
  Shinkai (2003) [94](#jcsm12502-bib-0094){ref-type="ref"}             601                Gait              m/s                                                                      Quartile lower                                     A    N
  601                                                                  Fast gait          m/s               Quartile lower                                                           A                                                  N    
  601                                                                  OLB                s                 Quartile lower                                                           A                                                  N    
  Sourdet (2012) [95](#jcsm12502-bib-0095){ref-type="ref"}             583                OLB               s                                                                        \<5                                                A    N
  Stenholm (2014) [96](#jcsm12502-bib-0096){ref-type="ref"}            727                Gait              m/s                                                                      Continuous (0.1)                                   A    Y
  727                                                                  SPPB               points            Continuous                                                               U                                                  Y    
  Takuhiro (2017) [97](#jcsm12502-bib-0097){ref-type="ref"}            104                RWS               m/s                                                                      SD (0.24)                                          A    Y
  Tanimoto (2013) [98](#jcsm12502-bib-0098){ref-type="ref"}            716                Gait              m/s                                                                      Lowest quartile (NR)                               U    N
  Terhorst (2017) [99](#jcsm12502-bib-0099){ref-type="ref"}            256                Balance           ---                                                                      NR                                                 U    N
  256                                                                  Forward reach      ---               NR                                                                       U                                                  N    
  Tinetti (2005) [100](#jcsm12502-bib-0100){ref-type="ref"}            1042               CST               s                                                                        Tertile[m](#jcsm12502-note-0029){ref-type="fn"}    U    N
  Volpato (2011) [101](#jcsm12502-bib-0101){ref-type="ref"}            74                 SPPB              points                                                                   \<8                                                U    Y
  Wennie Huang (2010) [102](#jcsm12502-bib-0102){ref-type="ref"}       65                 SPPB              points                                                                   Continuous                                         A    Y
  65                                                                   Gait               m/s               Continuous (1)                                                           A                                                  Y    
  65                                                                   BBS                points            Continuous                                                               A                                                  N    
  65                                                                   TUG                s                 Continuous                                                               A                                                  N    
  Zhang (2013) [103](#jcsm12502-bib-0103){ref-type="ref"}              504                CST               s                                                                        \<11.2                                             A    Y

*Physical Performance*: ---, not applicable or reported; 6MWT, 6 min walk test; BBS, Berg Balance Scale; CST, chair stand test; OLB, one leg balance; FRT, functional reach test; FT, full tandem; MWS, maximum walking speed; POMA, performance oriented mobility assessment; PPT, physical performance test; RGT, rapid gait test; RWS, regular walking speed; SPPB, short physical performance battery; ST, semi tandem; StS, side to side; TUG, timed up and go; UWS, usual walking speed; WS, walking speed. *Cut‐offs*: NR, not reported; SD, standard deviation. Expressed as either dichotomous, ranges for specific tertiles, quartiles, quintiles, or categories or per unit or score unless otherwise stated in brackets. AM, adjustment model denotes whether the model in the meta‐analysis was: A, adjusted; or U, unadjusted. MA, meta‐analysis; N, no; Y, yes.

≥1, 0.74--0.99, 0.57--0.73, \<0.57.

\<2, 3--9, ≥10.

Full tandem, semi tandem, side to side.

\<21.8, 21.8--24.3, 24.4--27.5, ≥27.6.

\<8.8, 8.8--10.3, 10.4--12.4, ≥12.5.

\<20, 20--40, ≥40.

15--27, 28--38, 39--41.

M: \>4.5, 4.0--4.5, 3.0--3.9, \<3. F: \>5, 4.0--5.0, 3.0--3.9, \<3.

M: \>20, 17.0--19.0, 11--16.9. F: \>21, 18.0--20.9, 12.0--17.9, \<12.

M: ≤1.08, ≥75: ≥0.82. F: ≤0.9, ≥75: ≤0.69.

M: 65--74: ≤1.81, 1.82--2.10, 2.11--2.36, ≥2.37. ≥75: ≤1.34, 1.35--1.64, 1.65--1.99, ≥2.00. F: 65--75: ≤1.45, 1.46--1.70, 1.71--1.98, ≥1.97. ≥75: ≤1.08, 1.09--1.34, 1.35--1.62, ≤1.63.

M: ≤18, ≥75: ≤5. F: ≤7, ≥75: ≤16.

\<9, 9--14, \>14.

Quality assessment {#jcsm12502-sec-0011}
------------------

A complete breakdown of the NOS can be found in *Table* [5](#jcsm12502-tbl-0005){ref-type="table"}. The majority of the articles were of high quality (46/83).

###### 

Quality assessment of included studies using a modified Newcastle--Ottawa Scale (NOS)

  First author (year) \[ref\]                                          Selection   Comp   Outcome   Total score               
  -------------------------------------------------------------------- ----------- ------ --------- ------------- --- --- --- -----
  Abete (2017) [24](#jcsm12502-bib-0024){ref-type="ref"}               1                  1         1             1   1   1   6/7
  Al snih (2004) [25](#jcsm12502-bib-0025){ref-type="ref"}             1                  1         2             1   1   1   7/7
  Albert (2015) [26](#jcsm12502-bib-0026){ref-type="ref"}              1                  1         0             1   1   1   5/7
  Alexandre (2012) [27](#jcsm12502-bib-0027){ref-type="ref"}           1                  1         0             1   1   1   5/7
  Amigues (2013) [28](#jcsm12502-bib-0028){ref-type="ref"}             1           1      1         2             1   1   1   8/8
  Arnau (2016) [29](#jcsm12502-bib-0029){ref-type="ref"}               1                  1         2             1   1   1   7/7
  Artaud (2015) [30](#jcsm12502-bib-0030){ref-type="ref"}              1                  1         2             1   1   1   7/7
  Basic (2017) [31](#jcsm12502-bib-0031){ref-type="ref"}               1                  1         0             1   0   0   3/7
  Baumgartner (2004) [32](#jcsm12502-bib-0032){ref-type="ref"}         1           1      1         2             1   1   1   8/8
  Beauchamp (2015) [33](#jcsm12502-bib-0033){ref-type="ref"}           1                  1         0             1   1   0   4/7
  Beloosesky (2009) [34](#jcsm12502-bib-0034){ref-type="ref"}          0                  1         0             1   1   1   4/7
  Bianchi (2015) [35](#jcsm12502-bib-0035){ref-type="ref"}             1           1      1         2             1   1   1   8/8
  Broadwin (2001) [36](#jcsm12502-bib-0036){ref-type="ref"}            1                  1         2             1   1   1   7/7
  Carriere (2005) [37](#jcsm12502-bib-0037){ref-type="ref"}            1                  1         2             1   1   1   7/7
  Cesari (2015) [38](#jcsm12502-bib-0038){ref-type="ref"}              1           1      1         2             1   1   1   8/8
  Chan (2014) [39](#jcsm12502-bib-0039){ref-type="ref"}                1                  1         1             1   1   1   6/7
  Chaudhry (2010) [40](#jcsm12502-bib-0040){ref-type="ref"}            1                  1         2             1   1   1   7/7
  Chu (2006) [41](#jcsm12502-bib-0041){ref-type="ref"}                 1                  1         2             1   1   1   7/7
  Cooper (2011) [42](#jcsm12502-bib-0042){ref-type="ref"}              1                  1         2             1   1   1   7/7
  Corsonello (2012) [43](#jcsm12502-bib-0043){ref-type="ref"}          0                  1         2             1   1   1   6/7
  Costanzo (2018) [44](#jcsm12502-bib-0044){ref-type="ref"}            1                  1         0             1   1   1   5/7
  Den Ouden (2013) [45](#jcsm12502-bib-0045){ref-type="ref"}           1                  1         2             1   1   1   7/7
  Denkinger (2010) [46](#jcsm12502-bib-0046){ref-type="ref"}           1                  1         2             1   0   1   6/7
  Di Monaco (2015) [47](#jcsm12502-bib-0047){ref-type="ref"}           1                  1         2             1   1   1   7/7
  Donoghue (2014) [48](#jcsm12502-bib-0048){ref-type="ref"}            1                  1         0             1   1   1   5/7
  Duchowny (2018) [49](#jcsm12502-bib-0049){ref-type="ref"}            1                  1         2             1   1   1   7/7
  Fantin (2007) [50](#jcsm12502-bib-0050){ref-type="ref"}              1                  1         0             1   1   1   5/7
  Femia (1997) [51](#jcsm12502-bib-0051){ref-type="ref"}               1                  1         0             1   1   1   5/7
  Fujiwara (2016) [52](#jcsm12502-bib-0052){ref-type="ref"}            1                  1         2             1   1   1   7/7
  Giampaoli (1999) [53](#jcsm12502-bib-0053){ref-type="ref"}           1                  1         2             1   1   1   7/7
  Gill (1996) [54](#jcsm12502-bib-0054){ref-type="ref"}                1                  1         2             1   1   1   7/7
  Gill (2009) [55](#jcsm12502-bib-0055){ref-type="ref"}                1                  1         2             1   1   1   7/7
  Guralnik (2000) [56](#jcsm12502-bib-0056){ref-type="ref"}            1                  1         2             1   1   1   7/7
  Hansen (1999) [57](#jcsm12502-bib-0057){ref-type="ref"}              1                  1         0             1   0   1   4/7
  Heiland (2016) [58](#jcsm12502-bib-0058){ref-type="ref"}             1                  1         2             1   1   1   7/7
  Hirani (2015) [59](#jcsm12502-bib-0059){ref-type="ref"}              1           1      1         2             1   1   1   8/8
  Hirani (2017) [60](#jcsm12502-bib-0060){ref-type="ref"}              1           1      1         2             1   1   1   8/8
  Hoeymans (1996) [61](#jcsm12502-bib-0061){ref-type="ref"}            1                  1         1             1   1   1   6/7
  Hong (2016) [62](#jcsm12502-bib-0062){ref-type="ref"}                1                  1         2             1   1   1   7/7
  Idland (2013) [63](#jcsm12502-bib-0063){ref-type="ref"}              1                  1         2             1   1   1   7/7
  Ishizaki (2000) [64](#jcsm12502-bib-0064){ref-type="ref"}            1                  1         2             1   1   1   7/7
  Janssen (2006) [65](#jcsm12502-bib-0065){ref-type="ref"}             1           1      1         2             1   1   1   8/8
  Jonkman (2018) [16](#jcsm12502-bib-0016){ref-type="ref"}             1                  1         2             1   1   1   7/7
  Kempen (1998) [66](#jcsm12502-bib-0066){ref-type="ref"}              1                  1         1             1   1   1   6/7
  Kozicka (2016) [67](#jcsm12502-bib-0067){ref-type="ref"}             1                  1         0             1   1   0   4/7
  Kwon (2012) [68](#jcsm12502-bib-0068){ref-type="ref"}                0                  1         2             1   1   1   6/7
  Legrand (2014) [69](#jcsm12502-bib-0069){ref-type="ref"}             1                  1         2             1   1   1   7/7
  Lopez‐Teros (2014) [70](#jcsm12502-bib-0070){ref-type="ref"}         1                  1         2             1   1   1   7/7
  McGrath (2018) [71](#jcsm12502-bib-0071){ref-type="ref"}             1                  1         2             1   1   1   7/7
  Minneci (2015) [72](#jcsm12502-bib-0072){ref-type="ref"}             0                  1         2             1   1   1   6/7
  Moen (2018) [73](#jcsm12502-bib-0073){ref-type="ref"}                1                  1         2             1   0   1   6/7
  Onder (2005) [74](#jcsm12502-bib-0074){ref-type="ref"}               1                  1         1             1   1   1   6/7
  Ostir (1998) [75](#jcsm12502-bib-0075){ref-type="ref"}               1                  1         2             1   1   0   6/7
  Peel (2014) [76](#jcsm12502-bib-0076){ref-type="ref"}                0                  1         1             1   1   0   4/7
  Pisters (2012) [77](#jcsm12502-bib-0077){ref-type="ref"}             0                  1         2             1   1   1   6/7
  Purser (2005) [78](#jcsm12502-bib-0078){ref-type="ref"}              0                  1         2             1   1   1   6/7
  Rajan (2012) [79](#jcsm12502-bib-0079){ref-type="ref"}               1                  1         2             1   1   1   7/7
  Rantanen (1999) [80](#jcsm12502-bib-0080){ref-type="ref"}            1                  1         2             1   1   1   7/7
  Rantanen (2002) [81](#jcsm12502-bib-0081){ref-type="ref"}            1                  1         1             1   1   1   6/7
  Rodriguez‐Pascual (2017) [82](#jcsm12502-bib-0082){ref-type="ref"}   0                  1         1             1   1   1   5/7
  Rothman (2008) [83](#jcsm12502-bib-0083){ref-type="ref"}             1                  1         2             1   1   1   7/7
  Sakamoto (2016) [84](#jcsm12502-bib-0084){ref-type="ref"}            1                  1         2             1   1   1   7/7
  Sanchez‐Martinez (2016) [85](#jcsm12502-bib-0085){ref-type="ref"}    1                  1         2             1   1   1   7/7
  Sanchez‐Rodrigeuz (2014) [86](#jcsm12502-bib-0086){ref-type="ref"}   0           1      1         0             1   1   1   5/8
  Sarkisian (2000) [87](#jcsm12502-bib-0087){ref-type="ref"}           1                  1         2             1   1   1   7/7
  Sarkisian (2001) [88](#jcsm12502-bib-0088){ref-type="ref"}           1                  1         2             1   1   1   7/7
  Schoenenberg (2013) [89](#jcsm12502-bib-0089){ref-type="ref"}        0                  1         0             1   1   1   4/7
  Seidel (2011) [90](#jcsm12502-bib-0090){ref-type="ref"}              1                  1         2             1   1   1   7/7
  Shimada (2010) [91](#jcsm12502-bib-0091){ref-type="ref"}             1                  1         2             1   1   1   7/7
  Shimada (2015) [92](#jcsm12502-bib-0092){ref-type="ref"}             1                  1         2             1   1   0   6/7
  Shinkai (2000) [93](#jcsm12502-bib-0093){ref-type="ref"}             1                  1         2             1   1   1   7/7
  Shinkai (2003) [94](#jcsm12502-bib-0094){ref-type="ref"}             1                  1         2             1   1   1   7/7
  Sourdet (2012) [95](#jcsm12502-bib-0095){ref-type="ref"}             0                  1         2             1   1   1   6/7
  Stenholm (2014) [96](#jcsm12502-bib-0096){ref-type="ref"}            1                  1         2             1   1   1   7/7
  Taekema (2010) [18](#jcsm12502-bib-0018){ref-type="ref"}             1                  1         1             1   1   1   6/7
  Takuhiro (2017) [97](#jcsm12502-bib-0097){ref-type="ref"}            1                  1         0             1   1   1   5/7
  Tanimoto (2013) [98](#jcsm12502-bib-0098){ref-type="ref"}            1           1      1         2             1   1   1   8/8
  Terhorst (2017) [99](#jcsm12502-bib-0099){ref-type="ref"}            1                  1         0             1   1   1   5/7
  Tinetti (2005) [100](#jcsm12502-bib-0100){ref-type="ref"}            1                  1         0             1   1   1   5/7
  Volpato (2011) [101](#jcsm12502-bib-0101){ref-type="ref"}            0                  1         0             1   1   1   4/7
  Wennie Huang (2010) [102](#jcsm12502-bib-0102){ref-type="ref"}       1                  1         2             1   1   0   6/7
  Zhang (2013) [103](#jcsm12502-bib-0103){ref-type="ref"}              1                  1         2             1   1   1   7/7
  Zoico (2007) [104](#jcsm12502-bib-0104){ref-type="ref"}              1                  1         2             1   1   0   6/7

Comp, comparability.

Only applied to studies that dichotomized sarcopenic cohorts.

Meta‐analysis {#jcsm12502-sec-0012}
-------------

### Muscle mass {#jcsm12502-sec-0013}

Two articles[60](#jcsm12502-bib-0060){ref-type="ref"}, [98](#jcsm12502-bib-0098){ref-type="ref"} evaluating muscle mass (low vs. high) and its association with ADL were included in the meta‐analysis. Low muscle mass was associated with worsening ADL \[OR = 3.19, 95% confidence interval (CI): 1.29--7.92, *I* ^2^ = 68.8\]. Four articles[28](#jcsm12502-bib-0028){ref-type="ref"}, [35](#jcsm12502-bib-0035){ref-type="ref"}, [60](#jcsm12502-bib-0060){ref-type="ref"}, [65](#jcsm12502-bib-0065){ref-type="ref"} were pooled into a meta‐analysis exploring the effect of muscle mass (low vs. high), which favoured worsening IADL (OR = 1.28, 95% CI: 1.02--1.61, *I* ^2^ = 75.8) (*Figure* [2](#jcsm12502-fig-0002){ref-type="fig"}).

![Forest plot showing the association between baseline muscle mass (low vs. high) with activity of daily living (ADL) and instrumental activity of daily living (IADL) at follow‐up. Heterogeneity (*I* ^2^): ADL = 68.8. IADL = 75.8. M, male; F, female. Articles that reported both ADL and IADL were denoted a and b.](JCSM-11-3-g002){#jcsm12502-fig-0002}

### Muscle strength {#jcsm12502-sec-0014}

Six articles[25](#jcsm12502-bib-0025){ref-type="ref"}, [27](#jcsm12502-bib-0027){ref-type="ref"}, [64](#jcsm12502-bib-0064){ref-type="ref"}, [72](#jcsm12502-bib-0072){ref-type="ref"}, [102](#jcsm12502-bib-0102){ref-type="ref"}, [105](#jcsm12502-bib-0105){ref-type="ref"} evaluating the association between handgrip strength (per 1 kg lower) and ADL were pooled, favoured worsening ADL (OR = 1.09, 95% CI: 1.05--1.13, *I* ^2^ = 87.5) (*Figure* [3](#jcsm12502-fig-0003){ref-type="fig"}A). Ten articles[24](#jcsm12502-bib-0024){ref-type="ref"}, [25](#jcsm12502-bib-0025){ref-type="ref"}, [40](#jcsm12502-bib-0040){ref-type="ref"}, [44](#jcsm12502-bib-0044){ref-type="ref"}, [49](#jcsm12502-bib-0049){ref-type="ref"}, [69](#jcsm12502-bib-0069){ref-type="ref"}, [81](#jcsm12502-bib-0081){ref-type="ref"}, [82](#jcsm12502-bib-0082){ref-type="ref"}, [83](#jcsm12502-bib-0083){ref-type="ref"}, [93](#jcsm12502-bib-0093){ref-type="ref"} were pooled into meta‐analysis demonstrating the association between low vs. high handgrip strength with ADL (*Figure* [3](#jcsm12502-fig-0003){ref-type="fig"}B). The pooled result again favoured worsening ADL (OR = 1.51, 95% CI: 1.34--1.70, *I* ^2^ = 50.0). Four articles[37](#jcsm12502-bib-0037){ref-type="ref"}, [87](#jcsm12502-bib-0087){ref-type="ref"}, [90](#jcsm12502-bib-0090){ref-type="ref"}, [93](#jcsm12502-bib-0093){ref-type="ref"} were pooled measuring handgrip strength (low vs. high) and IADL favouring worsening ADL (OR = 1.59, 95% CI: 1.04--2.41, *I* ^2^ = 94.7) (*Figure* [3](#jcsm12502-fig-0003){ref-type="fig"}B).

![Forest plot showing the association between baseline handgrip strength with activity of daily living (ADL) and instrumental activity of daily living (IADL) at follow‐up. (A) Handgrip strength (per 1 kg lower), heterogeneity (*I* ^2^) = 72.8. (B) Handgrip strength (low vs. high), heterogeneity (*I* ^2^): ADL = 50.0. IADL: 94.7. M, male; F, female.](JCSM-11-3-g003){#jcsm12502-fig-0003}

### Physical performance {#jcsm12502-sec-0015}

Seven articles[43](#jcsm12502-bib-0043){ref-type="ref"}, [45](#jcsm12502-bib-0045){ref-type="ref"}, [55](#jcsm12502-bib-0055){ref-type="ref"}, [72](#jcsm12502-bib-0072){ref-type="ref"}, [79](#jcsm12502-bib-0079){ref-type="ref"}, [96](#jcsm12502-bib-0096){ref-type="ref"}, [102](#jcsm12502-bib-0102){ref-type="ref"} evaluating the association between SPPB and ADL were pooled, which demonstrated that a lower SPPB score (per one point) is associated with worsening ADL (OR = 1.12, 95% CI: 1.07--1.18, *I* ^2^ = 91.8) (*Figure* [4](#jcsm12502-fig-0004){ref-type="fig"}A). Four articles[43](#jcsm12502-bib-0043){ref-type="ref"}, [56](#jcsm12502-bib-0056){ref-type="ref"}, [69](#jcsm12502-bib-0069){ref-type="ref"}, [75](#jcsm12502-bib-0075){ref-type="ref"} were pooled exploring the association between SPPB (low vs. high) and ADL (*Figure* [4](#jcsm12502-fig-0004){ref-type="fig"}B). The pooled effect favoured worsening ADL (OR = 3.49, 95% CI: 2.47--4.92, *I* ^2^ = 63.3). Two articles[29](#jcsm12502-bib-0029){ref-type="ref"}, [101](#jcsm12502-bib-0101){ref-type="ref"} combined ADL and IADL and showed that SPPB score (low vs. high) favoured a worsening of the combined ADL and IADL measure (OR = 3.09, 95% CI: 1.06--8.98, *I* ^2^ = 57.6) (*Figure* [4](#jcsm12502-fig-0004){ref-type="fig"}B).

![Forest plot showing the association between short physical performance battery (SPPB) with activity of daily living (ADL) and/or instrumental activity of daily living (IADL) at follow‐up. (A) SPPB (per 1 point lower), heterogeneity (*I* ^2^) = 91.8. (B) SPPB (low vs. high), heterogeneity (*I* ^2^): ADL = 63.3. IADL = 57.6.](JCSM-11-3-g004){#jcsm12502-fig-0004}

Seven articles were pooled in a meta‐analysis demonstrating the association of gait speed (per unit increase) with ADL (*Figure* [5](#jcsm12502-fig-0005){ref-type="fig"}A). After subgrouping for a lower unit (per 0.1 m/s, per 1 m/s and per SD) in gait speed, a lower gait speed of 0.1 m/s[76](#jcsm12502-bib-0076){ref-type="ref"}, [96](#jcsm12502-bib-0096){ref-type="ref"} was not associated with worsening ADL (OR = 1.64, 95% CI: 0.80--3.38, *I* ^2^ = 85.0) while a lower gait speed of 1.0 m/s[63](#jcsm12502-bib-0063){ref-type="ref"}, [72](#jcsm12502-bib-0072){ref-type="ref"}, [102](#jcsm12502-bib-0102){ref-type="ref"} and 1 SD[38](#jcsm12502-bib-0038){ref-type="ref"}, [74](#jcsm12502-bib-0074){ref-type="ref"} was associated with worsening ADL (OR = 4.40, 95% CI: 1.34--14.48, *I* ^2^ = 52.1; OR = 1.85, 95% CI: 1.44--2.36, *I* ^2^ = 62.8). Six articles[41](#jcsm12502-bib-0041){ref-type="ref"}, [49](#jcsm12502-bib-0049){ref-type="ref"}, [52](#jcsm12502-bib-0052){ref-type="ref"}, [58](#jcsm12502-bib-0058){ref-type="ref"}, [75](#jcsm12502-bib-0075){ref-type="ref"}, [93](#jcsm12502-bib-0093){ref-type="ref"} pooling gait speed (low vs. high) with ADL favoured worsening in ADL (OR = 2.33, 95% CI: 1.58--3.44, *I* ^2^ = 94.2) (*Figure* [5](#jcsm12502-fig-0005){ref-type="fig"}B). Four articles[37](#jcsm12502-bib-0037){ref-type="ref"}, [41](#jcsm12502-bib-0041){ref-type="ref"}, [62](#jcsm12502-bib-0062){ref-type="ref"}, [90](#jcsm12502-bib-0090){ref-type="ref"} evaluating the association between gait speed (low vs. high) with IADL demonstrated worsening in IADL (OR = 1.93, 95% CI: 1.69--2.21, *I* ^2^ = 0.0) (*Figure* [5](#jcsm12502-fig-0005){ref-type="fig"}B). Five articles[40](#jcsm12502-bib-0040){ref-type="ref"}, [44](#jcsm12502-bib-0044){ref-type="ref"}, [71](#jcsm12502-bib-0071){ref-type="ref"}, [82](#jcsm12502-bib-0082){ref-type="ref"}, [87](#jcsm12502-bib-0087){ref-type="ref"} were pooled comparing the lowest quintile for gait speed with the upper four quintiles with ADL demonstrated an association in worsening ADL (OR = 3.08, 95% CI: 2.13--4.46, *I* ^2^ = 75.7) (*Figure* [5](#jcsm12502-fig-0005){ref-type="fig"}C).

![Forest plot showing the association between gait speed with activity of daily living (ADL) and instrumental activity of daily living (IADL) at follow‐up. (A) Gait (per unit lower), heterogeneity (*I* ^2^): 0.1 m/s = 85. 1.0 m/s = 52.1. SD = 62.8. (B) Gait (low vs. high), heterogeneity (*I* ^2^): ADL = 94.2. IADL = 0.0. (C) Gait (lowest quintile vs. upper four quintiles), heterogeneity (*I* ^2^) = 75.7.](JCSM-11-3-g005){#jcsm12502-fig-0005}

Three articles[58](#jcsm12502-bib-0058){ref-type="ref"}, [93](#jcsm12502-bib-0093){ref-type="ref"}, [95](#jcsm12502-bib-0095){ref-type="ref"} were pooled demonstrating a strong association between one leg balance (low vs. high) and a decline in ADL (OR = 2.74, 95% CI: 1.31--5.72, *I* ^2^ = 88.5) (*Figure* [6](#jcsm12502-fig-0006){ref-type="fig"}A). Two articles[84](#jcsm12502-bib-0084){ref-type="ref"}, [89](#jcsm12502-bib-0089){ref-type="ref"} reported timed up and go (slow vs. fast) with ADL (*Figure* [6](#jcsm12502-fig-0006){ref-type="fig"}B). Slow timed up and go favoured worsening in ADL (OR = 3.41, 95% CI: 1.86--6.28, *I* ^2^ = 41.6). Three articles[55](#jcsm12502-bib-0055){ref-type="ref"}, [75](#jcsm12502-bib-0075){ref-type="ref"}, [103](#jcsm12502-bib-0103){ref-type="ref"} explored the effect of chair stand test time (slow vs. fast) with ADL (*Figure* [6](#jcsm12502-fig-0006){ref-type="fig"}B). Slow chair stand test favoured worsening in ADL (OR = 1.90, 95% CI: 1.63--2.21, *I* ^2^ = 0.0). Two articles[37](#jcsm12502-bib-0037){ref-type="ref"}, [103](#jcsm12502-bib-0103){ref-type="ref"} were pooled exploring the effect of chair stand test time (slow vs. fast) was not associated with worsening IADL (OR = 2.10, 95% CI: 0.80--5.48, *I* ^2^ = 74.8) (*Figure* [6](#jcsm12502-fig-0006){ref-type="fig"}C).

![Forest plot showing the association between other physical performance measures with activity of daily living (ADL) at follow‐up. (A) One leg balance time (low vs. high), heterogeneity (*I* ^2^) = 88.5. (B) Timed up and go (slow vs. fast), heterogeneity (*I* ^2^) = 41.6. (C) Chair stand test time (slow vs. fast), heterogeneity (*I* ^2^): ADL = 0.0. Instrumental activity of daily living (IADL) = 74.8. Articles that reported both ADL and IADL were denoted a and b.](JCSM-11-3-g006){#jcsm12502-fig-0006}

All meta‐analyses were ordered by study follow‐up duration from shortest to longest. No pattern was present based on follow‐up duration in all meta‐analyses.

Discussion {#jcsm12502-sec-0016}
==========

Muscle mass was associated with the development of IADL dependence. Muscle strength and physical performance were associated with the development of ADL and IADL dependence at follow‐up in older adults.

Muscle mass {#jcsm12502-sec-0017}
-----------

Surprisingly, muscle mass was associated with the development of new IADL dependence, but not ADL dependence at follow‐up in this meta‐analysis. While the association between muscle mass and ADL was not statistically significant, perhaps because of only two studies being included, a trend suggested that it was a clinically significant predictor of worsening ADL. The Concord Health and Ageing in Men Project reported that low muscle mass and sarcopenic obesity were significantly associated with worsening ADL and IADL.[60](#jcsm12502-bib-0060){ref-type="ref"} Additionally, a prospective study reported that low fat free mass was associated with functional disability.[36](#jcsm12502-bib-0036){ref-type="ref"} It has been previously hypothesized that muscle mass plays an important role in the loss of ADL with increasing age [106](#jcsm12502-bib-0106){ref-type="ref"}. Loss of muscle mass could be explained by a variety of different factors including the loss of innervation from alpha‐motor neurons [107](#jcsm12502-bib-0107){ref-type="ref"}, reduced dietary protein intake [108](#jcsm12502-bib-0108){ref-type="ref"}, [109](#jcsm12502-bib-0109){ref-type="ref"}, and less physical activity [110](#jcsm12502-bib-0110){ref-type="ref"}. Individuals with lower muscle mass have more difficulty in performing ADL and IADL [111](#jcsm12502-bib-0111){ref-type="ref"}, [112](#jcsm12502-bib-0112){ref-type="ref"}. Furthermore, it has been suggested that the infiltration of fat into the muscle is a risk factor for low muscle mass, which is associated with worsening ADL and IADL [111](#jcsm12502-bib-0111){ref-type="ref"}. Prior studies exploring the effect of training on muscle mass demonstrate its effectiveness in increasing performance and preservation of ADL and IADL [113](#jcsm12502-bib-0113){ref-type="ref"}, [114](#jcsm12502-bib-0114){ref-type="ref"}. Muscle mass has also been shown to improve in response to resistance exercise training and nutritional interventions, even in frail populations [109](#jcsm12502-bib-0109){ref-type="ref"}, [113](#jcsm12502-bib-0113){ref-type="ref"}, [115](#jcsm12502-bib-0115){ref-type="ref"}, [116](#jcsm12502-bib-0116){ref-type="ref"}, [117](#jcsm12502-bib-0117){ref-type="ref"}.

Muscle strength {#jcsm12502-sec-0018}
---------------

The predictive ability of muscle strength at baseline of ADL and IADL decline is consistent with a previous study consisting of 6089 participants, which suggested that having higher muscle strength was protective against the onset of future disability.[80](#jcsm12502-bib-0080){ref-type="ref"} However, the discrepancies in measures and cut‐offs and thus a lack of consensus in measuring muscle strength. Handgrip strength has been used as a measure of upper limb strength in older populations.[80](#jcsm12502-bib-0080){ref-type="ref"}, [118](#jcsm12502-bib-0118){ref-type="ref"} However handgrip strength should not be used as an approximation of overall muscle strength in older adults because of the variation between individuals and the variation in muscle groups within the same individual [119](#jcsm12502-bib-0119){ref-type="ref"}. Although a strong association between muscle mass and muscle strength exists [120](#jcsm12502-bib-0120){ref-type="ref"}, [121](#jcsm12502-bib-0121){ref-type="ref"}, [122](#jcsm12502-bib-0122){ref-type="ref"}, muscle strength may better predict worsening ADL and IADL as muscle mass can also be influenced by factors like disease, muscle use, and muscle morphology [123](#jcsm12502-bib-0123){ref-type="ref"}.

It has previously been hypothesized that there is a minimal amount of muscle strength required to complete ADL [124](#jcsm12502-bib-0124){ref-type="ref"}. Handgrip strength declines by 0.06 kg per year up to the age of 50 with an even steeper decline of 0.37 kg per year after the age of 50 years [125](#jcsm12502-bib-0125){ref-type="ref"}. In healthy older adults, large changes in muscle strength have little effect on ADL while small changes in a frail population have a more profound effect [124](#jcsm12502-bib-0124){ref-type="ref"}. This suggests that the completion of ADL and IADL requires a minimum threshold of strength and that higher muscle strength provides individuals with a protective reserve against the development of ADL and IADL dependence.[14](#jcsm12502-bib-0014){ref-type="ref"} Thus, individuals with lower muscle strength, and therefore a lower protective reserve, are at higher risk of developing new ADL and IADL dependence at follow‐up.[14](#jcsm12502-bib-0014){ref-type="ref"}

The prevalence of ADL and IADL dependence increases with age, muscle strength amongst older adults has been shown to decrease.[126](#jcsm12502-bib-0126){ref-type="ref"}, [127](#jcsm12502-bib-0127){ref-type="ref"}, [128](#jcsm12502-bib-0128){ref-type="ref"}, [129](#jcsm12502-bib-0129){ref-type="ref"} Gender has also been suggested to influence muscle strength as hospitalized older adults demonstrated an association between handgrip strength with ADL and IADL in male patients, but not female patients [112](#jcsm12502-bib-0112){ref-type="ref"}. Individuals with high muscle strength at baseline are also likely to preserve their higher handgrip strength at follow‐up [129](#jcsm12502-bib-0129){ref-type="ref"}. It would be expected that the association is stronger with longer follow‐up duration. However, this was not observed in our meta‐analysis. A reason this could be due to the different baseline ages and follow‐up duration between studies. Given that muscle mass decreases at a slower rate compared with muscle strength, it may be easier to preserve and maintain muscle mass, which can also prevent the decline in muscle strength.[130](#jcsm12502-bib-0130){ref-type="ref"}

Muscle quality, which refers to the muscle strength or power per unit of muscle mass,[131](#jcsm12502-bib-0131){ref-type="ref"} has been associated with worse ADL in a previous cross‐sectional study.[10](#jcsm12502-bib-0010){ref-type="ref"} As previous studies support the assumption that muscle strength decline occurs faster than muscle mass, it also suggests that muscle quality has likewise declined [130](#jcsm12502-bib-0130){ref-type="ref"}. Physical performance measured by gait speed has previously shown that a higher gait speed to be associated with higher muscle quality in older adults [132](#jcsm12502-bib-0132){ref-type="ref"}, [133](#jcsm12502-bib-0133){ref-type="ref"}. Currently, no studies have explored the association between muscle quality and worsening ADLs; however, as muscle quality has been shown to decline with age [134](#jcsm12502-bib-0134){ref-type="ref"}, [135](#jcsm12502-bib-0135){ref-type="ref"}, [136](#jcsm12502-bib-0136){ref-type="ref"}, it can be expected to observe similar results as muscle mass, strength, and physical performance.

Physical performance {#jcsm12502-sec-0019}
--------------------

Lower SPPB scores were associated with worsening ADL at follow‐up. The SPPB encompasses three assessments that require strength, balance, dexterity, and cognitive control, which captures functional elements that are required for the completion of ADL and IADL [137](#jcsm12502-bib-0137){ref-type="ref"}, [138](#jcsm12502-bib-0138){ref-type="ref"}, [139](#jcsm12502-bib-0139){ref-type="ref"}. Lower extremity physical performance measured by the SPPB was associated with worse ADL. Furthermore, a difference in score of 1 point on the SPPB was also significantly associated with worse ADLs as shown in this review and prior research [138](#jcsm12502-bib-0138){ref-type="ref"}. Lower SPPB scores are a reflection of impaired skeletal muscle function and structural changes associated with chronic inflammatory processes [140](#jcsm12502-bib-0140){ref-type="ref"}, as well as neurological pathologies that impair gait and balance [141](#jcsm12502-bib-0141){ref-type="ref"} that are thought to mediate the development of ADL and IADL dependence [142](#jcsm12502-bib-0142){ref-type="ref"}. High heterogeneity was observed between studies that evaluated the SPPB as a continuous variable compared with a dichotomous variable (low vs. high). The findings from this review were consistent with a previous systematic review, where the SPPB was predictive of long‐term disability.[143](#jcsm12502-bib-0143){ref-type="ref"}

Gait speed measured by a 4 m walk test is a component of the SPPB and is often used in clinical settings to identify individuals at high risk of adverse health outcomes[144](#jcsm12502-bib-0144){ref-type="ref"} and assist in the diagnosis of sarcopenia.[145](#jcsm12502-bib-0145){ref-type="ref"} Gait speed is both a simple and highly reproducible measure of physical performance and is comparable with the SPPB as a predictor of ADL dependence.[56](#jcsm12502-bib-0056){ref-type="ref"}, [146](#jcsm12502-bib-0146){ref-type="ref"} In community‐dwelling outpatients, the association between gait sped with ADL and IADL was stronger than its association with the other sarcopenia diagnosis criteria.[147](#jcsm12502-bib-0147){ref-type="ref"} While having a higher 0.1 m/s gait speed was not statistically significant in this study, all other analyses showed a lower gait speed favoured a worsening ADL and/or IADL. One study, which evaluated 27 200 community‐dwelling older adults for gait speed, demonstrated its predictive value on the development of disability.[148](#jcsm12502-bib-0148){ref-type="ref"} Other studies reported different cut‐offs for slow and fast gait speed, but no single threshold was evident with the incidence of disability.[148](#jcsm12502-bib-0148){ref-type="ref"} Therapies or preventative interventions targeted at improving or maintaining gait speed should be considered amongst older adults, as these changes are reflective of the progression and development of ADL and IADL dependence.[149](#jcsm12502-bib-0149){ref-type="ref"}, [150](#jcsm12502-bib-0150){ref-type="ref"} The findings of this meta‐analysis also resonate with a previous systematic review, which demonstrated that slow gait speed was associated with worsening ADL in older populations.[15](#jcsm12502-bib-0015){ref-type="ref"}, [151](#jcsm12502-bib-0151){ref-type="ref"}

One leg balance was significantly associated with worsening ADL in the follow‐up. The importance of balance is well described controlling both static and dynamic posture while performing a variety of daily activities,[152](#jcsm12502-bib-0152){ref-type="ref"}, [153](#jcsm12502-bib-0153){ref-type="ref"} such that it has been used as a predictor of high‐risk individuals prone to falls.[154](#jcsm12502-bib-0154){ref-type="ref"} Although one previous study reported no statistically significant association between one leg balance and ADL dependence, the three studies included in this meta‐analysis demonstrated a strong association between low one leg balance time and worsening ADLs.[155](#jcsm12502-bib-0155){ref-type="ref"} Timed up and go is a measure of walking, balance, strength, and cognition.[156](#jcsm12502-bib-0156){ref-type="ref"} A descriptive meta‐analysis exploring the cut‐off times of the timed up and go test reported cut‐off values of 8.1, 9.2, and 11.3 s for those aged 60--69, 70--79, and 80--99 years old, respectively.[157](#jcsm12502-bib-0157){ref-type="ref"} All studies included in the meta‐analysis[84](#jcsm12502-bib-0084){ref-type="ref"}, [89](#jcsm12502-bib-0089){ref-type="ref"}, [91](#jcsm12502-bib-0091){ref-type="ref"} had greater cut‐offs for a slow timed up and go time, potentially underestimating the pooled effect size. Timed up and go had a smaller effect size but less heterogeneity in predicting worsening ADLs compared with one leg balance in this meta‐analysis. Prior research comparing different measures of balance reported timed up and go as being a better predictor of ADL in older the community‐dwelling population.[158](#jcsm12502-bib-0158){ref-type="ref"}

The chair stand test was significantly associated with worsening ADL but not IADL. Chair stand test has been used as a measure of lower body strength in older adults in community‐dwelling older adults and as part of the SPPB.[11](#jcsm12502-bib-0011){ref-type="ref"}, [159](#jcsm12502-bib-0159){ref-type="ref"} A previous study reported that 22% of community‐dwelling older individuals are unable to complete the chair stand test (5 to 10 rises) without the use of hands and/or arms.[11](#jcsm12502-bib-0011){ref-type="ref"} The 30 s chair stand test may be a better protocol as it is more reliable given that some individuals are unable to complete standard protocols and the floor effect.[159](#jcsm12502-bib-0159){ref-type="ref"} Surprisingly, no studies included in the meta‐analysis reported the 30 s protocol; only the 5× chair stand test was used. High heterogeneity was observed in IADL perhaps because of the different cut‐off points used (11.2 s[103](#jcsm12502-bib-0103){ref-type="ref"} and 13 s[160](#jcsm12502-bib-0160){ref-type="ref"}) although this was not the case for ADLs.

Strength and limitations {#jcsm12502-sec-0020}
------------------------

This systematic review and meta‐analysis explored muscle mass, muscle strength, and physical performance as predictors for ADL and IADL rather than limiting to just a single measure. By evaluating the effects of all three measures, this review presented the most detailed assessment of this topic. To reduce the risk of reverse causation when interpreting the associations reported, only prospective studies were included. There are also limitations to this review. Not all studies were pooled into a meta‐analysis because of differences in measures and cut‐offs of muscle mass, muscle strength, and physical performance, the use of different statistical analyses, or the lack of data required to calculate an OR. Studies that were pooled were also reporting univariate and multivariate analyses, adjusting for different confounders that were inconsistent between studies that may have further led to an over or under estimation of the effect sizes. Studies that did not have a primary aim of exploring the association between baseline muscle measures with ADL and/or IADL may have used less standardized procedures. The follow‐up duration between studies varied significantly, which may have impacted the results.

Future recommendations {#jcsm12502-sec-0021}
----------------------

There were few pre‐existing studies that explored the association between baseline muscle mass and ADL and/or IADL. Studies should continue to investigate the association of muscle mass alone with ADL and/or IADL. Future studies should also explore the association of muscle quality with ADL and/or IADL. Interventions tailored for specifically increasing muscle measures should be developed to prevent individuals from having worsening ADL and/or IADL in their future. Interventions should be developed with the focus of preserving or increasing muscle measures as we age.

Conclusions {#jcsm12502-sec-0022}
===========

This study quantified the current research available between muscle measures and (I)ADL. Muscle mass is predictive of ADL and IADL decline whereas muscle strength and physical performance are predictive of both ADL and/or IADL decline. Future studies should continue to develop and improve interventions to preserve and improve muscle measures to prevent ADL and IADL dependence.
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